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ABSTRACT 
One hundred-twenty subjects were assigned to 
AP-100 enzyme motithwash, used twice daily, in a double-
blind treatment schedule for six weeks. They were divi-
ded equally into Part A and Part B, sixty subjects each. 
In Part A, subjects ,vere scored, then half of 
them were randomly assigned to placebo and half to 
AP-100 enzyme . . Removal of pre-existing plaque and 
treatment of gingivitis only were considered in this 
part. Part B, focused on reducing plaque accumulation 
and treatment of gingivitis. Therefore, all subjects 
in Part B underwent complete prophylaxis with a base 
line score equal to zero. 1 Gingivitis only was 
scored in this group and the subjects were randomly 
assigned half to AP-100 and the other half to placebo. 
Plaque and gingivitis were scored at three and six 
weeks. 
AP-100 enzyme sho\ved no significance · in: 
1) removal of pre-existing plaque, 
2) reduction of plaque accumulation and/or 
3) treatment of gingivitis. 
1 
L l 
BOS o_ U1. 
SL':rIOOL 0 
.. 
INTRODUCTION A?~D STATE?vf.ENT OF TlIE PROBLE11 
Dental plaque has often been implicated as the 
source of irritants which can initiate and perpetuate 
periodontal disease. Specifically, the microbial in-
habitants, as gram-positive and negative cocci and rods , 
of the plaque synthesize various enzymes, as collagenase, 
hyaluronidase, chondroitin sulfatase, and endotoxins 
which ~re potentially harmful to the gingival tissues. 
Various attempts have been made to prevent or 
reduce plaque formation. Several materials have been 
tried in vitro and in vivo experiments; antibiotics, 
enzymes, chelating agents, e t cete Pa ... None of those, 
however, have been standardized or attain the full 
effectiveness to fulfill all the requirements for an 
ideal plaque inhibitor. 
-
Based on past experience, both personal and in the 
literature, it appears that an oral flora is necessary 
as it is throughout the rest of the gastrointestinal 
system. This would suggest tl1at a substance ,;-1hich 
either interfers with the formation or disrupts the 
early matrix ':-1ould be desirable rather than altering 
the entire oral flora. The investigation to be 
2 
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reported in this thesis is based on two-part study to 
assess the efficacy and safety of AP-100 enzyme mouth-
wash in connection with: 
A. Removing pre-existing dental plaque; 
B. Reducing prospective accumulation of plaque; 
and 
C. Treating gingivitis. 
REVIEW OF LITERATURE 
The etiology of periodontal disease has been an 
issue of controversy and many debates. Present concepts, 
however, demonstrate a general agreement that the • "t1ICR0-
BIAL DENTAL PLAQUE'' is the primary etiologic agent for 
initiation of inflammatory periodontal disease. This 
concept has been postulated and demonstrated in a series 
of experiments by Loe et al., 1965, 1967; Theilade et al., 
1966; Jensen et al., 1968. 
In 1897, Williams described plaque as a "thick, 
dense and adhesive felt like mass of microorganisms." 
Recently, McHugh in 1970 defined dental plaque as the 
. 
soft tenacious bacterial deposit which forms on the 
surface of a tooth. No single precise definition, 
however, of this material can be given as the plaque 
is a variable and dynamic entity. 
Recent clinical and experimental research has 
shown that there is a strong relationship between the 
formation of plaq~e and the development of gingivitis 
(Loe et al.,1965, 1967; Theilade et al., 1966; Jensen 
et al., 1968; Gibbons, 1972; Socransky 1970). 
4 
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The control of plaque, therefore, must be based 
on active removal of soft deposits. Mechanical measures 
are effective in controlling plaque (Lovdal et al., 1961; 
Lightner et al., 1968; Suomi et al., 1969). There is, 
however, evidence from clinical practice and several 
group studies (Dahl and Davis, 1954; Massler et al., 
1957, Bratthall, 1966) to indicate that the technical 
ski~l, time, effort and perseverance required to con-
tinual~y maintain a high standard of oral hygiene, ex-
c~ed the ability of the average patient (Bay, 1967; 
Lindhe and Koch, 1967; Anerud, 1970). 
Socransky et al., in 1963, has shown that dental 
plaque consists mainly of bacteria, of the same order 
and magnitude as are found in the same weight of centri-
fuged culture of streptococci. Studies of developing 
dental plaque have revealed changes in the plaque flora 
with age (Hiep & Stallard, 1972). The cocci and 
rods which make up youn3 plaque are supplemented by 
filamentous organisms and fusobacteria after about a 
week (Carlsson and Egelberg, 1965; Theilade et al., 1966; 
Ritz, 1967) and there is some evidence that this change 
is associated with an increase in its pathogenecity to 
the gin~iva (Theilade et al., 1966, Jensen et. al.~ 1963; 
• 
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p O\'J e 11 , 19 6 9 ) . 
In addition, the presence of extra-cellular poly-
saccharides in dental plaque; the dextrans and levans, 
are important to the cohesion between bacteria in plaque 
and for its adhesion to the tooth (Carlsson and Egelberg, 
1965, Gibbons and Banghart, 1967; Critchley e t al., 1967; 
Guggenheim and Schroeder, 1967). 
Based on this new knowledge of plaque microbiology 
and chemistry, consideration has been given to the possi-
bility of controlling plaque formation by various sub-
stances. 
Fluoride: 
Fluoride was one of the first materials available 
for laboratory investigations. Bibby and Van Kesteren, 
. 
in 1940, demonstrated that fluoride concentrations of 
more than 250 p.p.m. prevented bacterial growth. Keyes 
et al., in 1966, using frequent topical applications of 
fluoride on hamsters found less plaque formed in treated 
. 
hamsters tl1an in non- treated hamsters. 
Clinical trials, bo,-1ever, have demonstrated many 
contradictions. Following treatment with sodium 
fluoride in . different concentrations (0.2-0.5%) 
• 
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with different periods of time, it was not possible to 
demonstrate any plaque reducing effect of inorganic 
fluoride. (Koch and Lindhe, 1967; Theilade et ai., 1970; 
Myers and Randleman 1971; Dolan and Kavanaugh, 1972; 
Frandsen e ·t al., 1972; Ka,,vanagh et al., 1974). 
In contrast, Woolley and Rickles, 1971; Birkeland, 
1972; Luoma et al., 1973; and Loesche et al., 1973 de-
monstrated through various clinical experiments that 
sodium fluoride reduced the amount of plaque formation. 
In addition, all the studies that were performed on · the 
organic fluoride have shown a positive reduction of 
plaque comparine them with inorganic fluoride (Dolan 
et al., 1972; Kauvanagh et al., 1974). 
Changing the Electric Potential of the Tooth Surfaces: 
Attempts have been made in vitro to change the 
electric potential of the tooth surfaces, by coating 
the teeth with an aminated or sulfonated polystyrene 
charged ion or two, exchange resin (Leung, 1954; Draus, 
Leung and Miklos, 1963; llofmann, Stallard and Schaf fer, 
1963; Schaffer, S~hindler and McHugh, 1964; Glantz, 
. 
1969). These studies represent interesting approaches 
to inhibit the adhesion of plaque, however, for the 
8 
moment there is no clue as to the clinical impact of 
this research. 
Inorganic Pyrophosphate: 
The possibility that inorganic pyrophosphate (PPi ) 
in body fluids may act as a physiologic inhibitor of cal-
cification was suggested by Fleisch and Neuman 1961 and 
has been supported by Feagin, Walker and Pigman, 1969. 
The presence of inorganic pyrophosphate (PPi ) in 
human parotid duct saliva in concentrations of approxi-
mately 0.1 ~1 have been reported (Sawinsky and Cole, 
1965; Vozel and Arndur, 1967). The work of Vogel and 
Amdur also suggested an inverse relation between sali-
vary inorganic pyrophosphate ( PP i) concentration and 
the rate of clinical supragingival calculus formation. 
Despite these facts, Hausmamann e t al., (1970) 
have reported extremely low inorganic pyrophosphate 
concentrations (0.1 - 0.5 mH) in parotid saliva. In 
view of this, it was surprising therefore that aqueous 
extracts of plaque (approximately 5 me. wet wei ght per 
Ml. at O degree Cent r igrade) were found to contain 
inorganic pyrophosphate at relatively high levels, and 
9 
moreover, the higher the concentration of inorganic pyro-
phosphate in the plaque, the slower the calculus forma-
tion on the teeth (Edgar and Jenkins, 1972). 
The possible relationship between plaque inorganic 
pyrophosphate and dental health is of interest, • as in-
organic pyrophosphate has been shown to inhibit calcifi-
cation in vitro (Fleisch and Bisaz, 1962) and to reduce 
the ' rate of acid dissolution of synthetic hydroxyapatite 
(Amdur· et al.,1963). 
At the present time, no sufficient investigatioM 
-has been forthcoming on the realtionship between plaque 
and inorganic pyrophosphate. 
Quaternary Ammonium Compounds and Phosphoramidates 
Quaternary -ammonium compounds possess well recog-
nized antimicrobial action and have been used as bacter-
iostatic and bactericidal agents. Bradosol, its active 
ingredient is a cationic detergent of the quaternary 
ammonium group. The use of this mouthwash for four days 
reduced the size of · the oral microcosm on many tooth 
surfaces, and changed its specific microbial content 
and staining characteristics (Arnim, 1963). 
10 
Another evaluation of the effects of a quaternary 
annnonium salt mouthwash and a surface acting agent 
(cytylpyridinium chloride) on plaque reduction has 
been made. Twenty-seven adults used their own tooth-
brush techniques in combination with a 30- second 
rinse of either the experimental or placebo mouthwash 
after brushing. After one week, the experimental mouth-
~ash showed a 38 percent decrease in stainable plaque as 
compared to either the placebo or a third mouthwash 
containing the surface acting agent only (Sturzenberger · 
and Leonard, 1969). 
All the quaternary ammonium compounds in vitro, 
inhibited plaque formation (McCabe e t a l., 1967; Gjermo, 
1970; Swing and Crawford, 1971). The in vitro plaque 
inhibition did not correlate well with the in vivo 
effectiveness (Gjerrno, 1970). However, the use of these 
compounds as suppressors of oral microflora has been 
somewhat limited. 
Heavy Metals and Victamine C 
The use of heavy metals,copper, silver, and mer-
. . 
cury salts, to inhibit plaque formation was suggested 
first by Hanke (1940). Later, all the experi~ents 
11 
were restricted to zinc. Zinc citrate, zinc phenol-
sulphate and zinc tribromsalan were tried as oral rinses 
showed a reduction in calculus (Picozzi 
et al., 1972) and plaque (Fischman et aZ., 1973). 
New material, Dodecyl ammonium 0-ethyl dodecyl-
phosphoramidate (Victamine C) was tried as oral rinse in 
comparison with zinc citrate and zinc tribromsalan and 
although the Victamine C showed reduction in plaque 
accumulation, zinc acetate and tribromsalan were more 
effective (Fischman et al., 1973). Chloromethyl Victa-
mine C, showed a marked decrease in plaque 
accumulation due to its cationic surface active chemical 
effect (Turesky : et al., 1970; 1971). 
GlyceroEhosphate and Phytic Acid: 
The plaque inhibiting of glycerophosphate 
and phytic acid has been su ·us tantia ted by Nordbo and Rolla, 
197~ 1972). They reported that phytic acid is more 
effective due to its competition with the organic plaque 
material on the tooth surface. 
Disclosing A3ents: 
Disclosing agents have been used for many years to 
reveal the presence and distribution of microbial depo-
• 
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sits on the teeth (Skinner, 1914). Arnim's study of 
disclosing agents in 1963 has resulted in the wide spread 
use of the dye erythrosin in solution or in wafer form. 
Erythrosin has been reported to have antimicrobial 
activity against nine streptococcal strains associated 
with dental caries and ten mixed microbial cultures 
representative of the oral microflora (Begue et a Z., 1966; 
Caldwell and Hunt, 1969). 
Chlorhexidine: 
Chlorhexidine, in the past few years, has received 
considerable attention due to its antibacterial action. 
Studies have demonstrated that when mechanical tooth 
cleansing is substituted with mouthrinsing or topical 
application of chlorhexidine, dental plaque and calculus 
do not form and gingivitis subsides (Loe and Schiott, 
1969 and 1970; Loe, Mandell, Derry and Schiott, 1970; 
Lindhe, Hamp, Loe and Schiott, 1970; Johnson and 
Kenney, 1972). 
Chlorhexidine was also incorporated in two ex-
. 
perimental toothpastes containin8 0.6 and 0.8 percent 
chlorhexidine digluconate, in which it showed a marked 
reduction of plaque formation (Gjermo and Rolla, 1970; 
• 
13 
Gjermo and Eriksen, 1972). 
Deleterious side effects with chlorhexidine, how-
ever, have been reported. Lindhe e t al. 1970 . desc-
ribed hemolysis, intravascular granulocytosis and 
thrombus formation when 0.2 percent chlorhexidine glu-
conate solution was applied to defective {epithelium not 
intact) cheek pouch surfaces in hamsters. Flora et al., 
1971 reported some desquamation and soreness of the 
oral mucosa after rinsing with 0.1 percent and 0.2 per-
cent chlorhexidine gluconate and acetate for a four-
month period. In addition, 36 percent of the test 
subjects developed discolored tongues and 33 perc ent 
complained of an objectionable taste. 
Alexidin (QR 7-11), which is an alternative to 
chlorhexidine, has been shown to possess the correct 
spectrum of activity and have extremely low absorption 
through the oral or intestinal mucosa. It is adsorbed 
by the enamel surface and its effectiveness in plaque 
inhibition has been demonstrated (Barnes et al., 1972; 
Gross e t al., 1972; Lobene et al ., 1973). The under-
standing of the mechanism of action of these drugs 
are still obscure and need further investi gations to 
overcome their disadvantages (Turesky, Glickman and 
• 
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Sandberg, 1972). In addition, more knowledge of the 
effect of such ecological shifts and possible side 
effects is needed before antibacterial substances can 
be introduced for clinical use. 
Antibiotics: 
Antibiotics result in caries reduction both in 
animals (McClure and Hewitt, 1946; Muhlemann et al., 1961; 
Keyes et al., 1966) and in humans (Zander, 1950; Little-
ton and li-fuite, 1964; Handelman et al., 1966) when ad-
ministered orally. Based upon the actual bacterial 
nature of the plaque, several antibiotic agents have 
been tested for their plaque-inhibiting capacity. 
Penicillin and tetr ·a.cycline have been shown to 
be highly effective in the control of plaque when added 
to the diet of experimental rodents. (Fitzgerald, 1955; 
Muhlemann et al., 1961; Larson e t al., 1966), or applied 
topically (l{eyes, 1966). Penicillin in chewing gum has 
also proven to be beneficial in the initial treatment 
of acute ulcerative . gingivitis (Emslie et al ., 1962) 
and three daily rinses with 0.25 percent tetracycline 
prevented bacterial plaque from forming (Loe et al ., 
1967). Spiramycin, an antibiotic produced by a new 
15 
species of streptomyces, was isolated from a sample of 
soil obtained from northern France (Durel, 1955). 
Spiramycin reduced bacterial colonization on rodent 
teeth and gingiva when applied topically, (Keyes et al. ., 
1966) and may also be of use in certain cases of perio-
dontal disease where bacteria ·may in time prove the 
most important etiological factor (Harvey, 1961). 
Vancomycin hydrochloride, by topical application, 
. 
inhibited the formation of dento-gingival plaque in ham-
sters (Keyes e t al., 1966), and an adhesive paste con-
taining 1 percent vancomycin was reported to reduce 
plaque (Aitchell and Holmes, 1965; Kaslick et al ., 
1973). Vancomycin, as a mouth'tvash, hovvever, is not 
effective as it resulted in a pronounced shift toward . 
a higher proportion of gram-negative bacteria in the 
gingival plaque \-lith only a few gram-positi ,.re cocci 
. 
and short rods (Loe et a l ., 1967) and it did not 
affect the thickness of the plaque at the gingival 
margin and gingivitis developed at its usual rate and 
severity in the human exp eriments (Jensen et al. ., 1968). 
A macrolide antibiotics (CC 10232) obtained from 
fermentation of a novel strain of strep t omyces c a elestis, 
.. 
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is also active against a variety of eram-positive micro-
organisms while gram-negative bacteria, yeasts and 
molds are not affected. This antibiotic reduced nlaoue • 
and calculus formation by approximately 70 to 75 per-
cent (Stallard et ai ., 1969; Volpe et al .1969) . 
. 
An erythromycin antibiotic study was conducted to 
test plaque inhibition in humans. After periods of one 
to eighteen \veeks with no tooth brusl 1 ing, there l1as a 
mean decrease in plaque of 35 percent in the erythromycin 
group as compared to the controls. Diarrhea and de-
velopment of drug-resistant strains of Microorganisms 
were noted (Lobene, Brian and Socransky, 1969). 
Kanamycine sulfate is a low molecular ,veight 
aminoglycan antibiotic. Topical application of five 
percent Kanamycin in orabase to the gingiva of mentally 
handicapped subjects, has shown significant reduction 
in the plaque scores and gingival scores (Loesche, 
Green, Kenney and Nafe, 1971; Loesche, Syed, Hockett 
and Nafe, 1972). 
Antibiotic compounds as lon~-term plaque control 
. 
agents cannot be considered effacacious. Topical 
17 
application of certain antibiotics may be indicated for 
short-term plaque control, such as in the immediate 
post-surBical healin g period, or in treating advanced 
cases of Vincent's infection. The drawbacks of anti-
biotics are: 1) Possible decrease in effectiveness 
when used against a systemic disease, 2) Selection of 
drug-resistant strains of microorganisms, 3) Increased 
growth of other portions of the oral flora such as can-
dida albicans, 4) Drug sensitivity, 5) Systemic side 
effects such as diarr~ea and nausea, which are caused 
by alterations of the body's bacterial flora, and 
6) Appearance o ~ a plaque composed of organisms not 
covered in the spectrum of the antibiotic drug used but 
still capable of producing dental disease. 
Sugars: 
The development and composition of dental plaque 
are influenced by the sugar content of the diet. 
Clinical trials have shown that frequent ingestion of 
sucrose gives rise to relatively lar g e amounts of 
plaque with a hiGh extracellular pol y sacch a ride con-
tent (Carlsson and E3 elber ~ , 1965; Carlsson, 1967; 
Carlsson and Sundstrom, 1968). It is also believed 
that sucrose is more cariogenic than glucose or 
18 
fructose (Forstell e t a l ., 1967). Sucrose was omitted 
from the diet of 19 men over a period of 14 weeks, and 
replaced by glucose syrup and calcium cyclamate. The 
results suggest that a reduction in the extent of plaque 
covering the teeth may occur after twelve weeks on a 
low-sucrose diet, although the soluble carbohydrate 
content of the plaque was raised during this period 
(Fry and Grenby, 1972). 
Plaq~e pH changes were studied in two groups of 
eighteen persons each,after a mouthrinse for thirty 
seconds with 50 percent solutions of sucrose, glucose, 
fructose, sorbitol and lycasin (hydrogenated starch 
hydrolysate). Sucrose markedly lo,-1ered the pll in the 
dental plaque as well as glucose and fructose, while 
sorbitol caused minute changes (Frostell, 1973; Fosdick 
et al., 1957 and ?1uhlemann 1969). In contradiction, 
Diana in 1972 conducted a study over a period of two 
years in eight monkeys. They were fed a diet con-
taining approximately 1 g./day o~ sorbitol. Efforts 
were made to exclude all sucrose from this diet. The 
results obtained suggest that sorbitol will neither aid 
the implantation nor support the continuance of a po-
tentially cariogenic flora. In addition, the capacity 
• 
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of the plaque to produce acid from sorbitol remained 
unaltered during the two-year experimental period. 
Enzymes: 
The formation of the plaque can be theorized 
into two types of bacterial adhesive interactions . First, 
. 
organisms must adhere to the acquired pellicle which 
fonps mainly by the rapid and selective adsorption of 
salivary constituents to the tooth surface. The second 
type of bacterial adhesive interaction starts durin g 
bacterial multiplicatio n . It binds the organisms together 
to form a cohesive mass which enables th em to accu mulate 
on the tooth surface. Th.ese interactions bet tveen 
bacterial cells are mediated by materials comprising 
the plaque matrix. This plaque matrix is polysaccharides 
(Gibbons and VanHoute, 1973). 
·E:nzymes have been used to pre ·ve11t or dissolve 
the matrix of the dental plaque. 
Mucinase dentifrices were used to reduce calculus 
formation (Ste'\ •1art, · 1952; Aleece and Forscl1er, 1954). 
Both studies concluded that mucinase reduced the 
total amount and softened the texture of formed cal-
culus. The latter study de111onstrated the a1:1ylolytic 
20 
mucinase "':·lylase L-1" to be more effective in reducing 
stain and preventing calculus than the proteolytic 
enzymes. 
Dehydrated pancrease, an enzyme powder, used once 
daily, application of the powder with toothbrush, • in 
addition to the usual routine of mouth care, reduced the 
amount of calculus depos ·its by 60 percent and the amount 
of inf1ammation of gingival tissues by 70-90 percent 
(Jensen, 1959; BaUI!lhanuners et al., 1968) . 
. 
• A pancreatin enzyme preparation in a chewing gum 
vehicle (Viokase) reduced the occurrence of dental cal-
culus in· a group of 19 calculus-forming subjects by 
24 percent in a split-panel test (Ennever and Sturzenber, 
1961). They concluded that a vehicle must be devised 
that allowed for increased contact time of the enzyme 
. with the teeth. t1ost subjects complained of an objec-
tionable taste, texture and odor (Allen and Courtney, 
1972). 
A clinical investigation was conducted to evaluate 
the effectiveness of a combination of enzymatic activi-
ties derived from pancreas as compared to combined 
enzymatic activities of fungal origin, in retarding 
21 
the deoosition of soft accretions, calculus and stain 
~ 
in the oral cavity. It was concluded that proteolytic, 
amylolyticdoes not establish the degree of therapeutic 
response as much as the enzymatic activities of fungal 
origin which are superior to those of dehydrated uan-
creas in retarding calculus formation (Packman e t al., 
196~; Harrison et al., 1963). 
The enzyme dextranase received considerable atten-
tion as a potential plaque control agent. Dextran is a 
polysaccharide compound synthesized by several plRque-
forming and cariogenic streptococci (Gibbons and Bnag-
hart, 1967). In vitro studies have indicated that the 
foli!lation of the plaque matrix is at least partially 
dependent upon the synthesis of insoluble dextran 
(Gibbons and Nygaard, 1968). 
A dextranase induced from penicillium funiculosum · 
was shown to disperse in vitro plaque formed by some 
oral bacteria. The plaques from different organisms 
varied in their susceptibility to the enzyme. 
It was noted that the type of tlextranase was dependent 
upon the type of dextran used in preparation of the 
enzyme (Fitzgerald, Keyes and Stoudt, 1968; Fitzgerald, 
22 
Spinell and Stoudt, 1968). 
Block e t al., (1969) reported the complete re-
moval of coronal plaque and striking reduction of 
gingival plaque after two days of using dextranase in 
sixteen-day-old golden hamsters. The drug was adminis-
tered inthe drinking water concommitantly with a high 
sucrose cariogenic diet. The control animals showed 
extens ·ive caries within 35 days while the treated 
animals had none. Hamsters above age 40 days seemed 
less affected by the drug, presumably because of the 
. increased number of actinomyces viscosus that form 
within the plaque with age. Actinomyces viscosus is a 
levan rather than a dextran producer and therefore is 
not dextranase susceptible. The in vitro effects of 
dextranase on extracellular polysaccharide-producing 
streptococci grown on autoclaved enamel sa~ples were 
evaluated by scanning electron microscopy. It has been 
sho¥m that dextranase is highly effective in dispersing 
both strains of streptococci when compared wit ~ con-
• trols (Hoffman e t al., 1973). 
Dextranase was also incorporated into chewing 
gum and was given to eight male dental students who 
• 
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participated in two different studies. In the first 
study, a commercial chewing gum was used during nine 
days as the only means of oral hygiene. During the 
second study, the chewing gum that contained dextranase 
was used. The comparison of both studies showed that 
dextranase is able to reduce plaque formation but did 
not prevent bacterial colonization in the dento-gingival 
areas . (Jenson and Loe, 1971) . 
. 
In the same year (1971), three clinical studies 
evaluated a dextranase contained in a mouthwas· . as an 
antiplaque effect. 
Caldwell et al. (1971) studied the effectiveness 
of a dextranase mouthwash in the prevention and removal 
of dental plaque in humans. In the first experiment, 
47 male dental students ceased all oral hygiene pro-
cedures and rinsed with a sucrose solution one minute 
followed by a placebo or dextranase mouthwash for one 
week. In the second study, thirty-six boys and girls, 
seven to ten years old who had plaque susc eptable to 
in vitro degradation by dextranase, used either a 
placebo or a dextranase mouthwash. They did not use, 
however, a sucrose mouthwash. In both studies the 
• 
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dextranses did not have a significant effect on either 
the chemical composition or the amount of plaque. 
A similar experiment v1as performed with the same · 
results (Nyman et a l •., ·1972)-. 
Lobene (1971) conducted a dextranase mouthw a s h 
study on seventeen males, age 18 to 24 years. The 
test period was three days, with the subjects rinsing 
eight times per day. The author cqncluded that the 
effect .of the dextranase varied greatly with the method 
used to estimate plaque accumulation. The dry weight 
of three-day plaque was reduced, but the area of the 
tooth covered with plaque was not altered. 
Ten human subjects were selected for their ability 
to form plaque containing streptococcus mutans. A de :,c-
tranase moutl1wash was used for five days~ Assays were 
performed to determine the dispersion of both preformed 
plaque and actively forming plaque. Dextranase reduced 
the amount of actively forming plaque but did not uni-
formly disperse plaque already present. The aut hors 
concluded that dextranase can promote the dis p ersion of 
dextraneous bacterial deposits if applied lon g enou gh 
' 
at a proper concentration and frequency (Keyes e t aZ .~971) 
. . . 
25 
Enzyme AP-100 
AP-100 is a new proteolytic enzyme preparation, 
produced by a mutant strain of Ba illus Subtilis, 
which is a mixture of neutral protease, alkaline protease 
and amylase in the ratio of 4:1:1. The enzyme proetolytic 
activity level is 10.000 units as determined by ·· . . 
equivalence with a casein substrate measured at 
pH 7. 
The in vitro efficacy of this enzyme was evaluated, 
by introducing a basal media of five percent sucrose to 
the human saliva on glass slides. Synthetic plaque was 
allowed to grow for four days, dried, weighed and 
reconstituted with distilled water. The levels of 
activity were tested, by immersing the samples in 
AP-100 solution, at five, ten, twenty and thirty thous-
and units of activity at one minute, two minutes, 
and five minutes. A sample of ten slides was used 
for each activity level. The experiment was repeated 
again using the same levels of activity and time. 
The results of both experiments were in statistical 
agreement. The reduction in plaque was linearly related 
to time and activity level on a logarithmic scale (Clini-
cal Brochure for AP-100 Enzyme, Marion Laboratories). 
26 
The acute toxicity of enzyme AP-100 was tested, 
by administering orally, 50 percent aqueous suspension 
for male and female rats. No histopathological altera-
tions of the animal's organs have been shown. Four 
mongrel dogs were given AP-100 enzyme orally. The 
acute minimum lethal dose was greater than 2,150 mg./kg. 
Dry powder in a dose of 1000 mg/kg. was retained by a 
single animal with no marked reactions during the 
fourteen days observation period. Higher doses (2.15 gm/ 
kg., 3.16 gm./kg., and 10.0 grn./kg.) produced emesis 
within twenty-five to thirty 4 three minutes. Also, AP-
. 100 ivas applied in the conjunctival sac of 110 rabbit 
eyes. One rabbit had a reaction in the iris and a con-
junctival effect in four others, after one hour score . 
Twenty-four hours later, all eyes were normal; this 
suggested that the minimal level of irritation seen 
previously may have been induced by mechanical means 
(clinical brochure for AP-100 Enzymes, Marion Labora-
tories). 
The subacute toxicity was tested by dividing 
eighty white rats into four groups, each group contains 
ten males and ten females. AP-100 tvas introduced in 
. the diets of three groups at dose levels of 20, 60 and 
• 
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200 mg./kg. The fourth group received no enzyme and 
served as the control. All groups received a sufficient 
amount of diet for seven days. The study was carried 
out for fourteen days. The body weight of each rat was 
recorded on Day 1, and at weekly intervals thereafter, 
as an index to growth. Statistical comparisons of final 
body weights and total weight gain revealed no sienifi-
cant differences between treated and control rats. Dur-
ing this period of study, all animals were observed 
daily for abnormal reactions and mortality. No deaths 
. 
occurred during the study period and no episodes of 
aberrant behaviour were noted. Hematologic and 
chemical blood studies and analyses of urine collected 
after thirteen days of feeding before the animals 
were sacrificed, revealed no differences between 
treated and control rats. After the animals were 
sacrificed, pathologic and microscopic examinations 
showed no unusual lesions or abnormal histological 
findings between the two groups. 
One percent solution of AP-100 was applied on 
designated areas of skin of 75 ~ale and 126 female 
human volunteers. A total of fifteen applications 
.. , 
were performed on each individual. Ten of these 
applications were covered, and for the rest, non-
occlusive cover was used. A typical irritation or 
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any changes of a primary irritation were not observed. 
By this human study of 201 volunteers, it v1as 
reasonable enough to predict 98.34 percent at least of 
the general population would not be sensitized to 
AP-·100 enzyme. 
Fifty patients were divided into two groups. 
The first group received the enzyme and the second 
group received the identically appearing placebo . 
-
Both groups were asked to rinse daily with the 
solution for three minutes prior to retiring. After 
four weeks, the enzyme group showed a 56 percent 
reduction in dental plaque from the baseline score, 
while the placebo group remained unchanged in 
score (Molle, 1966). 
-Also, twelve adult subjects were asked to 
use AP-100 as a concentrate in glycerine/alcohol 
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after their regular toothbrushing, once a day, without 
any attempt to motivate their habitual oral hygiene. 
The scoring was performed on projections of color 
slides for each subject's mouth. Each visible tooth 
in the projected slide was divided into six segments, 
three in the upper half and three in the lower half. 
Each segment was given a numerical value as follows: 
1 - trace of a deposit, 
2 - for a deposit covering less than half a 
segment, and 
3 = for more than half a segment. 
The study design was non-random cross over. The scores 
were obtained on each subject weekly for six weeks, 
while receiving AP-100 and then weekly for four wee ks 
while receiving placebo. Using this design allows 
each subject to serve as his own control. The result 
was fifty percent reduction of plaque in eight out of 
twelve subjects in the enzyme period of study while 
eight out of twelve subjects returned to within 70 
percent of the baseline values (Marion Laboratories, 
Inc.). 
... 
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The same study design was repeated using AP-100 
as a concentrate on twenty-one volunteers employing 
a four-point scale scoring technique. After nine weeks' 
use of AP-100, this group showed an average reduction 
in plaque of 30 percent, ,vith a maximum reduction during 
the sixth week of 46 percent. 
Twenty girls, ranging between fourteen to seven-
teen years, were divided randomly into groups A & B. 
Group A received the placebo and Group B received AP-100 
enzyme concentrate. Both groups had a full mouth pro-
phylaxis before the study initiated, as well as, instruc-
tions for the use of the product twice daily and routine 
brushing. 
The study was divided into three phases: 
PHASE I - On days O through 4, the subjects 
brushed their teeth and used the mouthwash. On days 
5 through 7, they refrained from brushing, using only 
the mouthwash. Utilizing a four-point scoring procedure 
on three segments of each tooth (Shaver and Schiff, 1970), 
plaque scores were recorded for both groups on day 8, 
PHASE II - Days 9 through 16 involved a regimen 
of both brushing and mouthwash. On Day 16, plaque was 
.. 
• 
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disclosed and scored again. 
PHASE III - Over the interval days 16 through 
30, the brushing and mouthwash regim en continued. 
Plaque was disclosed and scored again on Day 30. 
At the end of day 8, a difference of 21 percent 
in favor of the enzyme group was observed. On day 16, 
a difference of 36 percent was noted, and on day 30, 
a difference of almost 50 percent was evident. Some 
reduction in plaque was seen without brushing, but the 
combination of brushing and mouthwash was shown to have 
· the most significant effect (Marion Laboratories Inc.) . 
Forty-one office workers at Monsanto were ass ig n ed 
to AP-100 enzyme solution. Three quarters of them 
were male. They were randomly distributed into 
Group A and Group B without any attempt to select 
heavy plaque forMers. An average of 34 percent reduc-
tion of plaque occurred with the daily use of the enzyme 
mouthwash. The effect of the enzyme increased the 
first three weeks and then remained constant till the 
end of the six weeks period. A second examiner re-
peated a limited number of examinations, however, the 
subjects absences and the difference of interpretation 
• 
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in the scoring procedure of the second examiner 
precluded the statistical interpretation (Shaver and 
Shiff, 1970). 
In contradiction, Formicola e t al., in 1972, 
assigned eighty-seven black children to enzyme AP-100 
mouthwash and placebo in a randomized, double-blind 
par~llel group study design. On weekdavs, the children 
rinsed under supervision; on weekends ~, • • rinsing was 
unsupervised. Rinsing periods lasted for one minute, 
twice daily for thirty days. Plaque and gingival 
indices by Loe were scored on days 0, 7, 14, 21 and 30. 
Plaque \vas collected on the thirtie t h day to determine 
the plaque dry weights. Clinical photographs and 
bacteriological samples were obtained as well. There 
was no statistically signigicant reduction in the 
amount of existing plaque between the treatment and 
control groups as measured by the plaque index and 
the plaque weights. The degree of gingivitis as 
. 
measured by Loe and Silness Index was also not 
reduced. 
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Indices for the Evaluation of Periodontal Diseases: 
The main purpose of creating the Gingival Index 
System was to introduce a system for the assessment of 
the gingival condition which clearly distinguished be-
tween the quality of the gingiva (the severity of the 
lesion) and the location (quantity) as related to the 
four (buccal, mesial, distal, lingual) areas which make 
up the total circumference of the marginal gingiva 
(Loe and Silness, 1963). 
One of the early attempts to assess periodontal 
disease quantitiatively was the P.M.A. Index (Schour 
and Massler, 1948). According to this method (P.M.A. 
Index), the gingiva is divided into gingival units 
consisting of the interdental papilla (P), the marginal 
gingiva (M) and the attached gingiva (A). The criteria 
of assessment ,-1as graded numerically in successive 
degrees according to increasing intensity and extent 
as follows: 
0 "no inflannnation in any region of the mouth" 
. 
l+ - "mild gingivitis; localization of inflam-
mation usually to the interdental papillae 
or free gingival collar of one to three 
2+ -
3+ -
4+ -
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of six lower anteriors." 
"moderate gingivitis, extension of inflarmna-
tion to form a more or less continuous 
band along the marginal gingivae of more 
than thr(:!e regions of teeth." 
"severe gingivitis, extension of inflamma-
tion from the marginal ~ingivae into the 
attached gingivae, affecting almost all 
anteriors and soMe posterios." 
"very severe gingivitis, where Vincent's 
infection and other more severe stomatitis 
were included" 
In 1967, Russel came with another scoring technique; 
th~ Periodontal Index: 
0 
1 
2 
t-lega ti ve. There is neither over-inflaIDr.la-
. 
tion in the investing tissues nor loss 
of function due to destruction of support-
ing tissue. 
Mild gingivitis. There is an overt area of 
inflamination in the free gingiva which 
does not circumscribe the tooth. 
Gingivitis. Inflammation completely circum-
scribes the tooth, but there is no apparent 
break in the epithelial attachment. 
6 
8 
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Gingivitis with pocket formation. The 
epithelial attachment has been broken and 
there is a pocket (not merely a deep n d 
gingival crevice due to swelling in 
the free gingivae). There is no inter-
ference with normal rnasticatory function, 
the tooth is firm in its socket, and has 
not drifted. 
Advanced destruction with loss of masticatory 
function. The tooth may be loose; may 
have drifted; may sound dull on percussion 
with a metallic instrument; may be depressible 
in its socket. 
Massler in 1967, also defined the degree of gingivitis 
. 
for each gingival unit as follows: 
p 0 
1+ -
2+ -
3+ -
4+ -
5+ -
Normal; no inflammation. 
Mild papillary engorgement, slight increase 
• • in size. 
Obvious increase in size of gingival papilla; 
hemorrhage on pressure. 
Excessive increase in size with spontaneous 
hemorrhage. 
Necrotic papilla. 
Atrophy and loss of papilla through 
inflammation. 
M 
A 
0 
1+ -
2+ -
3+ -
4+ -
5+ -
0 
1+ -
2+ -
3+ -
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Normal; no inflammation visible. 
Engorgement; slight increase in size; 
no bleeding. 
Obvious engorgement; bleeding upon pressure. 
Swollen collar;spontan_ous hemorrhage; be-
gining infiltration into attached gingiva. 
Necrotic gingivitis. 
Recession of the free rarginal gingiva 
below the C.E.J. due to inflarrnnatory 
changes. 
Normal; pale rose; stippled. 
Slight engorgement with loss of stippling; 
... 
change in color may or may not be present . 
. 
Obvious engorgement of attached gingivae 
with marked increase in redness. Pocket 
formation present. 
Advanced periodontitis. Deep pockets 
evident. 
Ramfjord introduced in 1967, the Periodontal 
Disease Index (P.D.I.) which represents a combination 
of the P.M.A. and the P.I.: 
0 
1 
Absence of signs of inflammation. 
Mild to moderate inflaIIllllatory gingival 
changes, not extendine around the tooth. 
2 
3 
Mild to moderately severe gingivitis 
extending all around the tooth. 
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Severe gingivitis characterized by marked 
redness, swelling, tendency to bleed and 
ulceration. 
In 1967, Loe introduced the Gingival Index System. 
0 
1 
2 
3 
Normal gingiva: 
Mild inflammation- · slight change in 
color, slight edema. No bleeding on probing. 
Moderate inflammation - redness. edema and 
glazing. Bleeding on probing. 
Se,,ere inf lannna t ion marked redness and 
edema. Ulceration. Tendency to spontaneous 
bleeding. 
Ramjford introduced another measurement for 
plaque socring, the Periodontal Disease Index (P.D.I.). 
"Six teeth were measured - maxillary right first molar, 
maxillary left central incisor, maxillary left first bi-
cuspid, manidbular left first molar, mandibular right 
central incisor and mandibular right first bicuspid. Inter-
. 
proximal buccal and lingual surfaces were examined. 
Scoring of plaque was done. after staining the teeth with 
Bismark brown solution according to the followine 
criteria: 
. , 
0 
1 
2 
3 
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No plaque present; 
Plaque present on some but not on all 
interproximal buccal and lingual sur-
faces of the tooth; 
Plaque present on all interproximal 
buccal and lingual surfaces but 
covering not more than one-half of 
these surfaces; 
Plaque extending over all interproximal 
buccal and lingual surfaces and covering 
more than one-half of these surfaces. 
Only fully erupted teeth should be scored and 
missing teeth should not be substituted. Then indivi-
dual scores for each of the examined teeth should be 
added and divided by the number of teeth examined for 
mean score. 
More recently, this scoring technique has been 
modified by Shick and Ash in 1961. The modification 
consists of examining facial and lingual surfaces, but 
not interuroximal of the six selected teeth, and re-
• 
stricting the scoring of plaque to the gingival half 
of the surfaces. The use of a six tooth index has 
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been shown by Jamison (1960) and Shick and Ash (1961). 
Using the Shick-Ash Index, Rainey and Ash in 1964, 
found that the initial plaque score in their clinical 
study varied from 0.75 to 1.92. This means that none 
of the patients exhibited a mean plaque score beyond 
two-thirds of the gingival half of the facial or lingual 
surfaces. This observation would appear to validate 
the us .e of a scoring technique that accentuates 
differences in the gingival half of the tooth. 
The reproducibility of the scoring method, by 
the examiners, averaged a deviation for a single plaque 
:t- 0. 019 uni ts, (Smith and Ash, 1964). Rainey and Ash 
in 1964 found the deviation to be± 0.028. This degree 
of reproducibility is certainly adequate since it re-
presents less than three percent of the average 
plaque scores. 
A partial mouth scoring technique involving 
selected teeth was also employed by Stallard et al. 
(1969). They based their selection on the oral hygiene 
index simplified (OHI-S); (Green and Vermillion, 1964). 
They examined: buccal surfaces of upper right and left 
first molars, lingual .surfaces of lower rieht and left 
• 
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first molars, labials of upper right central and lower 
left central. The six teeth surfaces were painted with 
erythrosin disclosing solution and the patients rinsed 
to remove the excess. The amount of stainable plaque 
was graded as follows: 
0 
1 
2 
3 
-
- no stain present; 
stain covering not more than one-third 
of the tooth surface; 
stain covering more than one-third but 
not more than two-thirds of the tooth 
surface; 
stain covering more than two-thirds of 
the tooth surface. 
It has been suggested by Kupczak, Volpe and King 
(1969) that a numerical plaque scoring technique of 
zero to three could be used on a partial mouth basis 
with a high level of correlation with total mouth 
scores~ The authors found that the best results could 
be anticipated when the upper left first biscuspid, 
lower left cuspi~ and lower left bicuspid were utilized 
for the partial score. They also found that the plaque 
scores on lingual surfaces contributed very little 
to the meaningfulness of a subject's total plaque 
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score. This type of scoring would lend itself most 
readily to large population groups where the effect 
on gingival inflammation was not being considered. 
In terms of clinical testing, the procedures of Stal-
lard e t al. and Kupczak e t al. would have serious 
limitations in a dentifrice study where even the 
most haphazard brushing would be apt t o remove plaque 
from the incisal half of the teeth. It has an applica-
tion . to a non-brushing mouth rinse study, even though 
it appears to have limited application. 
Alexandre in 1970, recommended the following 
values: 
3 
2 
1 
no plaque; 
plaque accumulations up to one-half of 
the tooth surface and 
more than one-half of the surface. 
Lefkowitz and Robinson, 1962, also suggested 
a three-value system in which one-half of the tooth 
surface was the basis for the scoring. 
The Navy Plaque Index (modified) employed a 
scoring system that gives greater weight to plaque 
V 
in the immediate gingival area. The tooth is separated 
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into three major zones, the occlusal, the middle and 
the gingival zones. The gingival zone lies apical to an 
ima~inary line connecting the crests of the interdental 
papillae and roughly parallels the marginal gingiva. 
This area is subdivided into a mesial, distal and Middle 
zone, with each having a small area, not exceeding 1 mm. 
adjacent to the gingival tissue. The occlusal zone is 
coronal to the contact area or height of contour. The 
middle zone extends between the occlusal and gingival 
zones and is divided into mesial and distal areas. 
"By assigning all areas a score of one, more emphasis 
is placed on plaque adjacent to the gingival tissues, 
inasmuch as the surface area is much sm.aller". (Elliot 
. 
et al., 1972) . 
. 
Quigley and Hein in 1962 also reconnnended an index 
that gives greater attention to the gingival third of 
the tooth. They employed a partial mouth scoring pro-
cedure confined to the labial surfaces of the anterior 
teeth. Subjects rinsed with 20 ml. of a .075 percent 
basic fuchsin mouthivash and plaque scored as follows: 
0 
1 
2 
no plaque; 
flecks of stain at gingival margin; 
definite line of plaque at gingival margin; 
3 
4 
5 
gingival third of surface; 
two-thirds of surface; 
greater than two-thirds of surface per 
tooth surface per person. 
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Several investigators (Lobene, 1969; Turesky 
et al., 1970) have used the Quigley Hein Scoring System 
on ,labial buccal and lingual surfaces of the entire denti-
tion . . The only difficulty, however. would be the 
distinction between flecks of stain and a definite line 
of plaque. Tureskey et al., in 1970, more clearly 
differentiated the socring for the 1, 2 and 3 values 
and obviated some of the problems that could arise 
from.the original Quigley description, as follows: 
0 
1 
2 
3 
4 
-
-
no plaque; 
separate flecks of plaque at the cervical 
margin of the tooth; 
a thin continuous band of plaque (up to 
1 mm.) at the cervical margin; 
a band of plaque wider than 1 mm. but 
. 
covering less than one-third of crown; 
plaque covering at least one-third but 
less than two-thirds of the crown; 
5 = plaque coverine two-thirds or more of 
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the crown. 
This scoring technique used on all labial-buccal 
and lingual surfaces would provide a very comprehensive 
means of evaluating anti-plaque agents or procedures. 
The plaque thickness was an important considera-
tion in indexes. An index system for plaque score was 
introduced by Silness and Loe in 1964, and more fully 
described by Loe in 1967. Each of the four eingival 
areas of the tooth is given a score from O - 3; this 
is the plaque index (PLI) for the area. The scores 
from the four areas of the tooth may be added a n d divided 
by four to give the PLI for the tooth. The scores for 
individual teeth (incisors, premolars and molars) may 
be grouped to designate the PLI for the groups of teeth. 
Finally, by adding the indices for the teeth and divid-
ing by the number of teeth examined, the PLI for the 
individual was obtained. 
PLI = 0 was the score given when the gingival 
area of the tooth ~urface is literally free of plaque; 
PLI = 1 ·represents the situation where the 
gingival area was covered with a thin film of plaque 
which was not visible, but which was made visible by 
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running the probe in the gingival crevice. 
PLI = 2 is the score given when the deposit 
is visible in situ and 
PLI = 3 for the heavey (1-2 mm. thick) accumu-
lation of soft matter. Theassessment of plaque was 
made on top of calculus depo~its, on fillings and 
crowns. Since the gingival area constitutes the unit, 
the P~aque Index may be scored for all surfaces of all 
selected teeth or for selected areas of all selected 
teeth. Consequently, the PLI may be used in large 
scale epidemiological investigations as well as in the 
examination of smaller groups or within the dentition 
of individual. Recent analyses show no difference 
in the results when only one of the interproximal sur-
faces are examined instead of both, provided the score 
is given double load and the socre for the tooth is 
divided by four. 
One of the difficulties encountered in using the 
Silness-Loe index is the scoring of the interdental 
areas. The tendency is to score them from the facial 
aspect and assign a signle score to the lin gual area. 
Aina~o, in 1970, examined the interdental spaces from 
both lingual and facial aspects and assigned the greater 
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index value to the mesial or distal surface. Two recent 
studies lend support to the validity and reliability 
of the plaque index. Lang e t a Z., in 1972, found 
a nearly linear correlation between the index as used 
on the facial surfaces of anterior teeth and the total 
area of plaque as measured photographically (planirnetry 
of enlarged projections) with sodium fluorescein and 
a sp~cial light (black light). 
Shaver and Schiff in 1970, employed an estimated 
numerically scoring procedure which allowed a maximum 
number of twelve per tooth. Each tooth was ev a luated 
as three vertical seements as shown in the materials and 
methods. F'oreach s egment, a score of 1 indicated a trace 
of deposit, a score of 2 indicated deposit fallin g with-
in the gingival quarter of the segment, a score of 3 
indicated deposit falling within the gingival half of 
the segment and a socre of 4 indicated deposit extendin g 
into the incisal half of the segment. The buccal sur-
faces of all existing teeth from the first molar for-
ward in all four _quadrants were scored for a possible 
maximum mouth score of 288. 
A selective sampling of teeth for the examination 
has been felt to be of great importance. A selective 
. . 
• 
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sampling has to be based on a considerable amount of 
available information in regard to distribution of the 
disease to be sampled. The pattern of distribution 
of periodontal disease within the dentition has been 
studied by nermous investigators using: 
a) P.M.A. index for gingival manifestations 
(Massler et al.,1950) 
, 
b) probing and roentgenograms for the detec-
tion of formation of prockets and bone 
loss (Marshall-Day et al., 1955; Herulf. 
1951), and 
c) extraction records for det ermin a tion of 
the relative order of lost teeth (Brekhus, 
1928). 
Several attempts also have been made to divide 
the mouth into segments or sections (Mechta, 1956) 
for the purpose of sampling conditions in the various 
areas of the mouth. Various selected segments of the 
mouth also have been used as representatives of the 
entire dentition (?1assler et a l., 1950 and Parfitt, 
1957). 
Based on these available data and clinical ex-
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perience from practice and teaching, Ram·fjord in 1959 
selected the following teeth as indicators of the perio-
dontal condition within the dentition: 
Tooth number 3 (maxillary right first molar); 
Tooth number 9 (maxillary left central incisor); 
. Tooth number 12 (maxillary left first bicuspid); 
Tooth number 19 (mandibular left first molar); 
Tooth number 25 (mandibular right central incisor); 
Tooth number 28 (mandibular right first bicuspid). 
It was felt that a thorough examination of the 
periodontal status of these six teeth will provide a 
valid basis for an evaluation of the periodontal condi-
tion of the individual. 
MATERIALS AND METHODS 
Selection of the Subjects: 
In the selection of the subjects, special criteria 
were considered. 
1. The age of the patient was not less 
than eighteen years. 
2. The subjects were students and employees 
of Boston University. 
3. Subjects of either sex were admitted to 
the program. 
4. Scorable gingivitis was present. 
5. Scorable plaque was present. 
The criteria of the patients excluded from the 
study were: 
1. Subjects with normal gingiva. 
2. Minimal or absent plaque. 
3. Presence of severe cardiovascular, hepatic, 
renal or endocrine disease. 
4. Presence of severe periodontal conditions 
requiring surgical treatment. 
5. Absence of complete Ramfjord dentition. 
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6. Absence of anterior teeth to a degree 
preventing gingivitis scoring as pro-
posed by Massler. 
7. Pregnancy, or the likelihood thereof. 
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8. Inability to comprehend invalidating the 
principle of informed consent. 
9. Inability to comprehend and/or cooperate 
suggesting that the study medic a tion will 
not be reliably used according to instruc-
tions. 
and 
10. Recent or current ingestion of diphenyl-
hydantoin (Dilantin). 
Drug Supplies and Equipment: 
Packets of AP-100 powder, matching packets of 
placebo powder and three ounce paper cups for dissolv-
ing the powder was provided. The powder packets were 
packaged so that a three-week supply of medication 
could be dispensed at each visit. The active drug 
packets each contained 10,000 units of proteolytic 
enzyme. One packet of powder dissolved in bvo ounces 
of warm water constituted one dose. PLAK-LITE for 
plaque disclosure was used for all plaque evaluations. 
. ' 
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Blinding Procedures and Precautionary Measures: 
The active enzyme AP-100 powder and the plac~bo 
powder employed in this study were identical in appear-
ance, as were their containers and the glued-on portions 
of the container labels. Each label bore a tear-off 
portion containing a totally opaque, edge-sealed enve-
lope. The nature of the medication in any container will 
occur only on a card inside said envelope. The card 
can in no way be seen unless the envelope is opened. 
When the container of medication was dispensed 
according to treatment period and patient randomization 
schedule, the tear-off label portion was removed intact 
and affixed to the subject's report for~. The envelope 
was not to be opened at any time unless an emergency 
situation arose, such as the development of an acute 
reaction in a subject which made it imperative to know 
the nature of that subject's medication. 
Plaque and Gingivitis Scoring Methodologies: 
Only Ramfjord teeth were assessed (teeth 3,9,12, 
19,25 and 28). Three drops of sodium fluorescein dis-
closing solution, supplied with the PL.AJC-LITE Kit, was 
introduced on the lingual surface of the anterior teeth 
. .. 
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and the patient was asked to s,vish around ,,,ith his ton-
gue. 
The amount of plaque present at any examination 
was scored by a modification of the method suegested by 
Shaver and Schiff (1970). After the disclosing solution 
was applied and while stained material was fluorescing 
under PLAK-LITE illumination, the buccal surface of 
each Ramfjord tooth was scored on the basis of the 
area of plaque adhering to three equally divided vertical 
sections of the tooth, as shown in the figure below. 
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The three vertical sections were subdivided into 
three horizontal segments from the top: a proximal g in-
gival quarter, a distal gingival quarter and an incisal 
half for each vertical segment. 
FINDING 
No deposit 
Trace of deposit 
More than a trace of 
deposit in proximal 
gingival quarter 
Deposit extending into 
distal gingival quarter 
Deposit extending into 
incisal half of segment 
SCORE 
0 
1 
2 
3 
4 
The buccal surfaces of all six Ramfjord teeth were 
scored, three sections summed per tooth, for a possible 
plaque score of 72. 
In the gingivitis scoring, only the ei ght anterior 
teeth were used as ~uggested by Massler (1950). No 
special equipment such as FLAK-LITE wa s required. The 
gingival Index of Loe (1967) was used. Each of the four 
gingival areas of each of the eight Massler teeth were 
scored according to the following clinical findin gs. 
FINDING SCORE 
Normal gingiva 0 
Mild inflammation; 
slight change in 1 
color, slight edema, 
No bleeding on probing 
l1oderate 
redness, 
glazing. 
probing. 
inflammation; 
edema and 
Bleeding on 
Severe inflammation; 
marked redness and 
2 
edema. Ulceration; 3 
tendency to spontaneous 
hemorrhage. 
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The four scores for each tooth (buccal, mesial, 
distal and lingual scores for each) are sununed. Then, 
the total scores for all eight teeth were added together, 
and the sum divided by 32 to obtain the gingivitis score. 
The maximum gingivitis score will, thus, be 3;00 and the 
quotient expressed to the nearest hundredth. 
Stratification, Matching, Randomization: 
In order to fairly compare results of treatment, 
subjects entering either PART A or PART B of this 
study were stratified into: 
a) Severe "S" Group where their plaque 
• 
score was 37 or greater and/or gingivitis 
score 1.51 or greater; 
or 
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b) Mild "M" Group, t-1here their plaque score 
was 36 or less and/or gingivitis score 1.50 
or less. Whenever a conflict existed, ~.g., 
mild plaque and severe gingivitis coexisting, 
the presence of one severe score for either 
finding placed the subject in the severe "S" 
Group. 
SeparatE~ computer-generated randominzation sche-
dules were employed for each study PART ''A" and "B" 
and within those parts for each disease severity group 
"M" and "S". These schedules ensured proper randomiza-
tion and stratified assignments of the blinded treat-
ments, active enzyme powders, or placebo powders. The 
supplies of medication were numbered by "Mtt or "S" 
prefix and subject number suffix to ensure proper dis-
pensing. Additionally, the medication labels were 
coded "A" or "B" to ensure correspondence ,vith the 
proper part of the study. For exa mple, the subject 
AS4, is the fourth subject to be assigned to the "Severe" 
Group in PART "A" of the program, and subject BM 30 for 
.. 
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the last individual to enter the "Mild" Group in PART 
"B" of the study. 
Subject Block Assignment: 
Each subject entering the study was assigned to 
one of four "blocks", as shown below. Each block con-
taining thirty subjects. 
art 
M Group 
Subject num-
bers AM-1 
through AM-30 
n tis group 
there were 30 
subjects with 
mild disease 
not undergoing 
prophylaxis, 
half assigned 
to AP-100 and 
half to place--
ho. 
Stu 
S Group 
Subject num-
bers AS-1 
through AM-
30 
Int is 
group there 
were 30 sub-
jects with 
severe dis-
ease, not 
undergoing 
prophylaxis, 
half assign-
ed to AP-100 
and half to 
placebo. 
p 
M Group 
Subject num-
bers BM-1 
through BM-30 
Int is group 
there were 30 
subjects with 
mild disease 
who did re-
ceive initial 
prophylaxis; 
half are then 
assigned to 
AP-100 and 
half to pla-
cebo. 
S Group 
Subject numbers 
BS-1 through 
BS-30 
Int 1.s group 
there were 30 
subjects with 
severe disease 
who did receive 
initial prophy-
laxis; half are 
then assigned to 
AP-100 and half 
to placebo. 
Study Procedures in Detail by Numbered Patient Day: 
Subjects in PART '~B" received a complete perio-
. 
dontal prophylaxis on their first day of entering the 
study, while subjects entering PART "A" did not have any 
dental prophylaxis. 
Day 01: 
Day 21: 
1. The subjects were selected according to 
the criteria mentioned beforehand; 
2. The study is explained to the subject 
and written Informed Consent obtained (see 
Appendix); 
3. The subject is scored for plaque and 
gingivitis and assigned to Group "M" or 
"S" within PART "A" or "B"· , 
4. "B" subjects received complete oral 
prophylaxis, while "A" subjects did not; 
5. All subjects received the instruction 
and were given medication for the next 
three weeks; 
5. Day 01 case report are completed in 
full. 
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1. The subjects returned with the medication 
containers and any unused powders. Packet 
count was performed and written; 
2. The subjects were scored for plaque and 
gingivitis; 
3. The oral cavity was examined for possible 
. Day 42: 
58 
irritation or other adverse effects of medi-
cation; 
4. The subjects were questioned for any side 
effects or adverse reactions; 
5. Reinforcing instructions were given; 
6. Enzyme was dispensed for the next 
three weeks. 
7. Day 21 case report forms were completed 
in full . 
1. The subjects returned with the medication 
containers, and any unused powders from the 
second treatment period; 
2. The subjects were scored for plaque and 
gingivitis; 
3. The oral cavity was inspected for every 
subject for any possible irritation or other 
adverse effects of medication; 
4. The subjects were questioned for any 
subjective side effects or adverse reactions; 
5. Day 42 case report forms were completed, 
including final drug accountability sections. 
6. Subjects were released from the study. 
• 
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(See Appendix for complete set of score forms) 
Subject Instructions and Dosa8e Regimen: 
1. The subjects weie informed as to the na-
ture and details of tre study, including both 
possible unpleasant or adverse effects or 
hazards and possible benefits which they 
may experience. Each subject was provided with 
an informed -consent in writing, and this docu-
ment was suitably witnessed. A copy of the 
subject's consent document was made a portion 
of each subject's case report form. 
2. The subjects were requested to discontinue 
the use of water-pulsating equipment and 
dental floss, if either or both of these were 
already being used. All kinds of ancillary 
dental hygiene procedures, such as Stim-U-Dent 
and toothpicks were not allowed. 
3. Subjects were asked to continue only with 
"ordinary and customary" toothbrushing with the 
usual dentifrice and usual technique. 
4. The subjects were taught the proper use 
of the three-ounce paper cups and the medica-
tion powders: how to dissolve the powders in 
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warm water filling the cup two-thirds, and to 
use the resulting mouthwash solution twice 
daily. 
5. The subjects were asked to use the mouth-
wash twice daily, at each time, to retain the 
solution in their mouth, swishing it around, 
for one full minute or as near thereto as 
possible. They were instructed to use a watch 
or clock to · time each rinse. Subjects were 
instructed to take two or three successive 
increments of the solution into their mouth 
to utilize all two ounces, leaving no portion 
of the two ounces unused. 
6. Residual mouthwash should not be rinsed 
away immediately with water; it should only be 
expectorated. 
.. 
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RESULTS 
Group A result was summarized in the form of 
responders and non-responders. Reduction of 30 per-
cent of plaque from the baseline score was considered 
a responder. The following table sho~~,s the number 
of responders in the third and sixth week. 
TABLE I 
PLAQUE 
GINGIVITIS 
AP-100 
Placebo 
AP-100 
Placebo 
GROUP A 
Wk 3 
Responders 
7 
4 
5 
8 
26 
25 
22 
13 
20 
22 
It appears from this data that AP-100 has an effect 
on the sixth week. By applying chi-square analysis to 
the above series of contingency tables provided the 
following statistical outcomes between AP-100 and 
placebo. 
17 
10 
13 
PLAQUE 
GINGIVITIS 
GROUP A 
WK 3 
N.S. 
N.S. 
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WK 6 
p .10 
N.S. 
From the results, AP-100 showed slight signifi-
.cance in week 6 only in reducing plaque; however, it 
did not show any significance for the gingivitis. 
Since Group B had a complete oral prophylaxis, 
it was unnecessary to apply the chi-square analysis as 
they had a baseline score= 0. 
Table# II contains the results of Group A 
and Bin terms of plaque. The t-values were applied 
to show the difference bet\'1een the baseline score, 
week 3 and week 6, for AP-100 and placebo respectively. 
Both AP-100 and placebo shov1ed statistical significanc~ 
from week 3 and week 6 and the baseline sco~e. How-
ever, by applying a non-paired t-test to show if there 
is a difference between AP-100 vs. placebo, it sho·wed 
non-significant difference. 
Furthermore, combining subgroups (mild and 
severe) in Group A and in Group Band running the 
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same tests it showed no significant difference between 
AP-100 and placebo. (See Appendix for Computer Results) 
Table fl III contains the results of Group A and 
Bin terms of gingivitis. Difference oft-values between 
week 3, week 6 and the baseline score are shown in this 
table, applied on AP-100 and placebo individually for 
both groups A & Band subgroups (mild and severe). Signi-
ficant difference was shown in case of the AP-100 or 
the placebo i11dividually comparing them ·with the base-
line score. However, in finding the difference between 
AP-100 vs. placebo, it showed no significance. 
Combining both subgroups (mild and severe) in 
Group A & B, it showed no statistical diff erence be-
tween AP-100 and placebo. 
see appendix) 
(For computer results, 
Table II and III showed a sienificant difference 
in case of the AP-100 or the placebo individually com-
paring them with the baseline score. This signigicant 
difference may be . interpreted by the motivation of 
the subject$ when they had instructions for using the 
mouthwash. However, by comparine AP-100 vs. placebo in 
non-paired t-test, it showed no statistical ~i 6nificance 
between them whether in controlling plaque or gingivitis 
for all groups of the study. 
TABLE II 
P L A O U E 
. .. 
AP- 100 PLACEBO AP- 100 vs. PLACEBO 
GRP SEV. BASE WK. 3 WK. 6 BASE WK. 3 WK. 6 BASE WK. 3 WK. 6 
A M MEAN 29.5 26.4 19.9 28.5 26.0 21 . 3 
S.E. 1 . 0 1 . 4 1 • 4 .5 1 • 0 1 • 3 
N 17 17 17 16 16 16 33 33 33 2 1--'- 6 3 ........... 
- 2. 3* - 4.8-k'R' y·'-. 9 .2 , ... t - , ... - . ",, -• • 
A s MEAN 45.8 32.5 26.3 44.7 35.4 29.4 
S. E. .6 1 • 7 1 • 6 .6 1 • 2 1 • 5 
N 14 13 13 15 14 14 29 27 27 
t - 7.2 * -1 2 . 7 *">'( - 7.9* -l 0. 4 ** 1 • 2 - 1 . 3 'l'c° - 1 • 4 ')(·k 
B . M MEAN 29.3 24.4 20.3 27.6 26. 1 21 • 3 
S. E. 1 • 3 1 • 6 l • 7 1 • 1 1. 6 I • 6 
N 13 12 12 16 15 15 29 27 32 
t - 5. 4* - 9.a~•r . 9* - 4.8 ** 1 . 1 • 7--,'r 4 .. , .... ,( - - - .,  ., • 
B s MEAN 46.2 34.4 23.4 45.0 34.5 22.7 
S.E. . 7 1 . 0 1 • 4 1 . 0 1 . 1 1 . 0 
N 16 16 16 17 17 16 33 33 32 
t - 9. 3* -13. 5 --,'(* - 6. 7* -13.7*..,'t: 1 • 0 - • 1 * .4 
A MEAN 36.9 29. 1 22.7 36.4 30.4 25. 1 
S.E. 1 . 6 1 • 2 1 . 2 1 . 5 1 . 2 1 . 2 
N 31 30 30 31 30 30 62 60 60 
t 
- s. 1 * - 9. 8 *·k - 5. 6·1< 
- 8. 5 ** .2 - . S·k - l. 4 *-!: °' 
.i:--
B MEAN 38.7 30. 1 2 2. 1 36. 5. 30.6 22.0 
S.E. 1 • 7 1 • 3 1 • 1 1 • 7 1 . 2 .9 
N 29 28 28 33 36 31 62 60 59 
t - 8. ]·;'c - I 0. 4 *·k - 4. 7--,< 
- 8. O ** .9 - 3* .o • 
·k Di£ f erence of t-values bet~-.1een week 3 & base 
# 
·-k* Difference of t-values between week 6 f :; base 
• 
TABLE III 
- ~ T N G I V I T I s 
AP-100 PLACEBO AP-100 vs. PLACEBO 
GRP. SEV. BASE WK. 3 WK. 6 BASE WK. 3 WK. 6 BASE WK. 3 WK. 6 
A M MEAN 1 . 4 1 • 1 .8 J • 5 I • 2 
.9 S.E. .2 .s . 0 . 2 • 1 
. 5 N 17 17 17 16 16 16 33 33 33 t 
- 1 • 5-,\- - 1. 5** - 2. 2-.'r - 2. 6-k* 
.3 - 1 • p•: - 1 . 0 ;'(-;'( 
A s MEAN 2.0 1 . 4 1 • l 1 . 9 1 • 4 1 . 2 , S. E. .o .0 . • 1 .o .o .0 
N 14 13 13 15 14 14 29 27 27 ·k·k t 
- 8. 4* -11 • 7 ,~·k 11.1*- 1 J. 4 ** .8 . 6 -
- 1 • 5 
B M. ttAN 1 • 2 1 . 1 .9 1 • 2 l . 1 
. 9 S. E. . 0 . 1 .. 1 . 1 • 1 • 1 N 13 12 12 16 15 15 29 27 27 t - 1. 2* - 3 .. 0 •k-;'( 
-
• 9';'( 3. 5 ·k·k 
.2 • 1 .2 
B s MEAN 2.0 1 • 3 1 • 0 J • 9 1 . 3 .9 S.E. .o .o • 1 .0 
.0 . ) 
N 16 16 16 17 17 17 33 33 33 t -18k 
- l 7. 4 *i< 
- 8. 8·k - 1 0 • 6 -.Jc'( 2.3 • 1 . 7 
A MEAN 1 . 6 1 . 2 
-9 1 • 7 1 • 3 1 • 0 S. E. • 1 .o . 0 • 1 • l .o N 31 30 30 31 30 30 62 60 60 t - 3.6 *- 6. 2 -;'rn 
- 5 · 5·k - 5. 6 *~~ - .3 1 • o·:: 1 . 5 *-1-: °' - - Vt 
B MEAN 1 • 6 1 • 2 
.9 1 • 5 . 1 . 2 
.9 S.E. • l .o .o • 1 .0 .o N 29 28 28 33 32 32 62 60 60 t - 6.3')'( - 7. 9 -!c'~ 
-
5. O ')':-
- 7. 2 ·k* 1 • 0 . 2 .] 
.• .. Difference of t-values bet~veen tveek ") rind the t,ase. ,. .J 
, ...,•,~•c Difference of. t--v.1 lucs be tv1ccn '"·1ecl (, nn<l the h,1.SC . 
11ild Plaque 
Severe Plaque 
GROUP B 
\-leek 3 
AP-100 Placebo 
X 24.4 
S.E. 1.6 
t value 
Signfificance 
Level 
X 34.4 
S.E. 1.0 
t Value 
Significance 
Level 
26.1 
1.6 
- . 7 
N.S. 
34.5 
1.1 
- . 1 
N.S. 
?1ild Gingivitis 
X 1.10 1.09 
S.E. .07 .07 
t Value .1 
Significance 
Level t~. s. 
Severe Gingivitis 
X 1.31 1.31 
S.E. .03 .03 
. t Value .1 
Significance 
Level N.S. 
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Week 6 
AP-100 
20.3 
1.7 
Placebo 
21.3 
1.6 
- . 5 
N.S. 
23.4 22.7 
1.4 1.0 
.4 
N.S. 
.92 .90 
.07 .06 
.2 
N.S. 
.95 .89 
.06 .06 
.7 
N.S. 
"Table ·rv' Results Taken from Tables II & III 
to answer Formicola's question. 
Patient 
Number 
BM-14 
BM-24 
BM-28 
AS-10 
AS-27 
AM-14 
TABLE V 
· Adve ·rse Reaction 
Developed canker score last 
week of study. 
Gums were tender after one 
week. Discontinued use 
for two days. 
Gums swollen some after 
use of dentifrice 
Didn't like it (Not a 
side effect) 
Redness on tongue, may 
not be related to 
mouthwash. 
No side effect registered 
(Error) Patient female, but 
recorded as male. 
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Drug or 
p·1acebo 
Placebo 
AP-100 
AP-100 
Placebo 
Placebo 
AP-100 
From the table shown, no particular reaction 
was common in two or more cases. Minimum reaction 
occurred to six patients which does not seem to be 
related to AP-100 enzyme. 
, 
AGE AND SEX SUMMARY 
, 
00-09 · 10-19 20-29 
M F 
AP-100 0 
0 0 
PLACEBO 
, 0 
0 0 
MEAN 
AP-100 32.4 
PLACEBO 33.4 
TABLE VI 
M 
3 
0 
0 
0 
F M F 
24 
3 9 15 
29 
0 11 18 
AGE 
S. D.. N 
10.3 
9.6 
58 
61 
30-39 
M F 
17 
7 10 
17 
9 8 
40-49 50- 59 
M F 
8 
5 3 
10 
5 5 
SEX 
M F 
25 33 
26 35 
M F 
6 
4 2 
5 
1 4 
60-69 
M F 
0 
0 0 
0 
0 . 0 
From the table shown above, the range of age selected was 
between 20 years and 40 years. Attempts were made to 
select 50 percent male and 50 percent females. 
;. ll WWW ::t:.J 
70- 79 80-89 90-UP 
M F 1·1 F M F 
0 0 0 
0 0 0 0 0 0 
0 0 0 
0 0 0 0 0 0 
DISCUSSION 
In this study, althoug~ a different scoring tech-
nique was utilized, coincides with the reults of Forrni-
cola et al. (1972). Formicola used Plaque Index 
Scoring technique which indicated approximately eight 
percent plaque reduction in the treat~ent group and he 
substantiated the results of the Pl. I .. by measuring 
the dry · weights of plaque which showed no significant 
difference. As a leading result, no statistically 
measurable difference in gingivitis was shown as well. 
Also, by counting the viable microbial cells, no signi-
ficant reduction in the treatment group was shown by 
comparison with the placebo group. 
In contradiction, Shaver and Shiff in 1970, in 
their evaluation of AP-100 enzyme, reported 34 percent 
reduction of plaque with the daily use of this enzyme 
as a mouthwash. They selected 41 subjects without 
any attemtp to separate heavy plaque formers. The 
scoring technique was nearly the same as performed 
. 
in the present study, dividing each tooth into three 
vertical segments, scoring all the buccal surfaces from 
the first molars forward with a maximum mouth score of 
288. The study was double-blind treatment without 
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anv J 
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stratification. They disclosed plaque by using Amurol 
disclosing tablets containing two percent FD & C 
red #3. The variation of the results of the present 
study may be related to: 
1. The difference in number of patients, 
may alter the significance of the 
statistical interpretation, 
2·. The lack of stratification may have 
led to the selection of a fairly high 
number of non-plaque formers, 
3. The variation of the disclosing agents 
which may contribute to a difference in 
the visibility of the stained deposits 
on different levels of the tooth, 
4. A difference in interpretation, between 
several investigators, of the scoring 
procedures which may result in a gross 
difference in the total score. 
In order to avoid any discrepancies, the plaque 
scoring was perfo~med only by the investigator, and 
also a slight modification of the method suggested 
by Shaver and Shiff in 1970 was added, by sub-dividing 
the vertical sections into three horizontal segments; 
. . 
.., 
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a proximal gingival quarter, 
a distal gingival quarter, and 
an incisal half (See Materials & Methods). 
Ramfjord teeth were selected for plaque scoring. 
Accoring to Ramfjord in 1959, scorin3 of these six 
teeth will indicate an accurate evaluation status for 
the entire individual, as it was felt that scoring of 
all the teeth for each individual would be time con-
suming with the number of subjects in this study. 
The subjects in this study were promptly strati-
. . 
fied to each group. The stratificati on of the subjects 
was given special consideration in order to assess the 
ef f ica c i ty of the enzyme in terms of ,reduc±nt ··: the 
formation of plaque in those who had initial prophyla x is 
or prevent the plaque formation or gingivitis in those 
who had not undergone an oral prophylaxis. 
The primary objective for selecting the g in g ival 
index by Loe was to assess the quality of the gingiva . 
without considering the pocket depth or degrees of bon e 
loss or any other quantitative chang e of the periodon-
tium. Although some scoring error may have occurred 
due to the difficulty encountered in distinguishing 
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between moderate inflammation (2) or severe inflamnation 
(3), Russel's periodontal index was not chosen because 
it indicates two scores for gingivitis, scores 1 and 2 
only, and the next score, which is 6, includes pocket 
formation. This index does not consider different 
quality of gingival inflammation or the degrees of 
severity of the pathological condition, but merely to the 
horizontal extension of the marginal inflammation around 
the tooth. The P.M.A. Index (See Literature Review) by 
Schour and Massler was also considered, but this index 
scores the extension of gingivitis from the marginal 
gingiva to the attached gingiva. As it was not anti-
cipated that the mouthwash could exert any treatment 
effect on the attached gingiva, the Loe index was of 
the first preference. 
Ramjord's Periodontal Disease Index has three 
scores for · gingivitis (Scores 1, 2 and 3). Although 
these scores do represent increasing severity of the 
inflammatory lesion (See Literature Review) mild, 
moderate, severe, , it . sets a definite criteria to the 
extension of the pathological process along the 
circumf e Pence of the tooth, and the individual tooth 
represents the unit area, while in the Loe gingival 
index, it refers to the individual tooth surfac e 
• 
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as the unit area and consequently, the criteria for th e 
different scores are qualitative. No standardized gin-
gival index is available, however, the gingival index 
by Loe proved to be the most ideal system to fulfill 
the requirements of this study. 
It can be observed in Table I that there is an 
increasein the number of responders at six weeks in terms 
of plaque and gingivitis. By applying chi-square test 
for Group A, no statistical significance could be shown 
between AP-100 enzyme and placebo, whether in reducing 
plaque or improving gingivitis. This result coincides 
with Formicola e t al. (1972). Part B of the study was 
performed to answer the questions asked by Formicola. 
If this enzyme was of some benefit to reduce the accumu-
lation of plaque and control gineivitis? Table IV 
demonstrated that enzyme AP-100 produces neither 
effect. 
As seen in the in vitro studies (See Literature 
Review), enzyme AP-100 has a positive eff e ct on plaque 
formation while in this clinical study, the result was 
reversed. Several factors may contribute to the failure 
of the enzyme: 
a) the environment of the oral 
cavity may not be the same as in 
vitro studies; 
b) the time and exposure of the 
enzyme to the plaque in vitro studies 
were well controlled . rather than the 
washing action of the saliva in the 
oral cavity, and 
c) the neglect on the part of some 
of the participants in using the 
enzyme mouthwash regularly. twice 
·daily or reducing the rinsing 
period in part of the subjects 
or wahsing away the enzyme by 
direct rinsing with water which 
may not ·give the optimum time for 
the enzyme to produce the same effect 
as in the in vitro studies. 
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All the studies performed on enzym e AP-100 as a 
. 
mouthwash through an effervescent tablet dissolved in 
water or as a powder diluted in water are in contro-
versy. Some showed positive results (Shaver and 
Shiff, 1970) and others produced negative results 
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(Formicola e l al., 1972) including this study; while 
all the studies performed on AP-100 as a concentrate 
showed positive results. Accordingly, we can assume 
that using the enzyme as a mouthwash is not the best 
vehicle for this study. Further studies on AP-100 
should be carried out on the enzyme in other vehicles 
in order to provide time for the exposure of the 
plaque · to the enzyme. Also, rinsing one minute twice 
a day, may not have been the optimum time to permit 
· adequate exposure of the plaque to the enzyme, there-
fore, an additional time daily may be beneficial. 
From the above discussion, it appears that 
a need for a vehicle which can carry the enzyme against 
the plaque in the mouth of a patient for one minute is 
a requirement for substantiating the efficiacity of 
enzyme AP-100. The simplest method suggested is to 
carry the powder on the bristles of the toothbrush 
and brush the teeth normally to insure that the enzyme 
is on all teeth surfaces, wait for one minute and then 
rinse with water. In addition, the enzyme is a con-
centrate of a glycerine and alcohol may be a good 
vehicle to keep the enzyme against the plaque for a 
longer period of time. 
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SUMMARY AND CONCLUSION 
Over the years, the addition of proteolytic 
enzymes to oral hygiene products have been reported 
in a number of patents and publications (U.S. Patent 
1915, 1923, 1934, 1963, 1965). The present study is 
an attempt to inhibit plaque formation by means of a 
prot"eolytic enzyme derived from a mutant strain of 
bacill\.ls subtilis which is a mixture of neutral prote a .. 
alkaline protease, and amylase in the ratio 4:1:1. 
The study was conducted in two parts: Sixty 
subjects were studied in each. In Part A, removal of 
pre-existing plaque and treatment of gingivitis only 
were considered. Half of the subjects in Part A were 
randomly assigned to AP-100 and the other half 
to placebo. A double-blind treatment schedule was 
conducted for six weeks. Scoring for plaque and 
gingivitis was performed at zero. three and six · 
weeks. 
Part B focused on reducing plaque accumulation 
. 
and treatment of gingivitis. After plaque scoring to 
document that the subjects were indeed plaque formers, 
the subjects underwent complete prophylaxis with re-
moval of all plaque. Gingivitis was scored and the 
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subjects randomly assigned to AP-100 or placebo. After 
three and six weeks, plaque accumulation and severity 
of gingivitis was scored. 
In conclusion, results obtained in this human 
study indicated that AP-100 enzyme as utilized, is not 
satistically significant: 
1) in removal of pre-existing plaque, 
2) reduction of plaque accumulation 
and/or 
3) treatment of gingivitis. 
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Labur<1Lor t, , llH. 
City, Missouri 64137 
AP-100 (enzyme mouthwash) 11038 
Study No.: 038-001 
Principal Investigators: Henry Coldman, o.n.s. 
~-0_0_1 ___ j ___ _ 
Product Study Patient 
Code No. No. 
Patient ~o. 8~ ' 33 
Richard E. Stallard, D.D.S., Ph.D. 
CONSENT F0~'1 
THIS F0Rl1 IS PROVIDED J;J TP.IPLI AITJE .?., :~...,R (.VO-C,tRBO:J-F?EQUI.~£!J) PA ER. U E ELA~.:. ?4.:C 
PEN AND PRESS FIP.!.JLY. AVOID WRITl:JG OV PAPERS L,11D OVER Tl!IS PAGE. m115 ',./HITE -:.: : J-
INAL SHOULD BE ATTACHED TO '!'HE CASE R~PORT FOR/.! FOR ':HIS PATIENT, FOR ~u SEQUENT 
TRANSMISSI0/1 TO !lfARIOI/ lABORATORIES, Il/C. THE YELLOW COPY SHOULD BE GIVF/l TO HE 
PATIEi~T FOR RETENTI0,1. TllE PI ,'IK COP1 IS TO BE RETAJ.1go Ill THE I1lVESTTGAT08 'S F' _ uE.,.,. 
1. AP-100 is a combination of enzymes (complex molecules which bring about or accel-
erate biochemical reactions) which is presently classified as an investigational 
new drug in the United States. The study in which you are being asked to partic-
ipate is design~d to determine, if possible, whether AP-100 will b useful in 
removing pre-existing dental plaque, or in reducing the rate of plaque accumu-
lation, or in the treatment of gingivitis (inflammation of the gums). 
2. You will receive packets of either AP-100 powder or a placebo {a powder with no 
enzyme activity). The contents of the packets will be dissolved in water, and the 
solution will be used twice-a-day as a mouthwash. During the six-week study period 
the only dental care you will use will be th e test mouthwash and normal brushing 
with your usual toothpaste. You will be asked not to use water-pulsatin·g quip-
ment, dental floss or ocher similaT devices during the study. 
3. · No side effects are expected with the use of AP-100. However, there is a remut~ 
chance that allergic sensitization could occur. Also, as with any unfamiliar 
substance, irritation of the tissues of th e .mouth is possible. Anything unpi~asant 
or alarming should, of course, be report ed to your d ntis.t promptl y , Richard E. 
Stallard, D.D.S., Ph.D •• University: i62-4200, Ext. 6229, Home: 631~0179 or 631-
9177. 
4. I am not taking any medication at present other than that reported to the Prin-
cipal Investigator. Should I begin drug therapy of any kind during the study, I 
will report it illlQediately to Dr. Richard E. Stallard, telephone 262-4200, Exe. 
6229. 
--n-------n------------------~---------- --~~ 
I, ~l...[.[AOJ (lo ~D ft,,#ZJ voluntarily co ns en t to participate in this . 
study to determine the us ef ulness of AP-100 in th e management of dental plaque and 
gingivitis. It has be~n explained to me that this is an investigational new drug. The · 
possible benefits and the possible adverse effects and ha zards of this program have 
been explained to me. I understand that this investigation vill be conducted under the 
supervision of Dr. Richard E. Stallard, and th I n wi thdraw from the study at any 
tr.ff0 .----./4 n> 
(j ~ 
--~,.._---=~-~ =-----=-~ ---------r _!). D. 
signature 
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White- Marion Medical Yellow- Patient Copy Pink- Investigator 
J1;a1ion J.;~l•ur .11ur1l' :,, 1n · • 
Kant;a!; Cily, lU.:,,:lHtri 
CASE tEPO!~T VOT~ f
---·-· -------- --
Al>-100 (cn7.j"•7lC mout.h\,'aLlh) 0038 
Study :~o. 038-001 
-- -- ---Principal lnvt •:.;t j~,.ai..or: Henry Goldma..!!.J_D.D.S. 
I __ l~_L _____ _ 1 
Product Study l';,i t. j c1 , t.: 
Code: No. l'o. 
------ --- - -- -- --------4----ALL Ei!Ti~I l:S f;HOCLD ~~E 1•:lTIIEP TYPf.\!i~JTTE:. O:l P!~Ti:TtD J: - J;L~\Cl" B,\LI. PC:L Tlll S 
---- -FORH lS 1 ~: TR]l'L) C,\TE 0/ ucrr (::o-c; l!l~0,1-r.EQUinT:D) P,\PEr, . PRESS FllUtLY \·.11Ll~~' 
USIN(: 1:1.J.!._llO . . :OT ~:?~JTE o;, r \P[ ~S L1 ID AC:i~O~S TllFSC PAGES . __________ _ 
Date t /.:Ji?: I '7¥ 
Name /3c-/-: rQ___.;./._}_J._~ _________ _ Patient umber 
Lust First U. I. · 
ASSl_G~PtE1!T OF J'ATJr:: :T "TU. fJ~ER (<..:heck one in each section) 
I. Tre~tmcnt Grouo 
-----
A. D rart A C-to plaque removal before entrance to study) 
:t. ElJ Part B (Complet e prnphylaxi.s with all plaque removed - plaque and 
gingivitis scored before prophyla~is) · 
II. · Severity 
· A. D Hild (Plaque score* 36 or: less AND gingivitis score* 1. 50 or le ss ) 
B. ~ Sev ere (Plaqu e score* 37 or greater A!1D/OR gingivitis score;': 1. 51 
or greater) 
• 
*PlAquc and gingivitis scores from the Serial Observations Section of th is 
Case RC!:port Form, pages 2 and 3. 
GENERAL 
--- -
Age ;l G, (yrs) Height S 8>01 (in/cm) Sex@ 1 0 F 
llISTOn~ (List any significant djseases within the last two years) 
-----~'-----·------------------------------
RECENT Dl' lJG HISTORY 
Drug 
(I.it.t any drugs taken within the last month, \.Jhcther 
prescription or proprietary) 
Dose Uates of Use (from-to) Reason for u~c 
--
~lite - Mnrlon McdJcal Yell~g - Marion Biostatistics Pink - Inve~tis~t or 
AV-JOO (<:IIZJ'Ml' rnnuth-Jilsh) 0038 
Study t~o • __ 0 .38-:00 l
r~~J •' I t=J 
Product Study l'.1t S,·r.t 
Pr f nc J s,a 1 J n vr 3 ti eat or : __ H_c_n_r_y _ G_o_l_d_m._a_n .. __ D_. D • S • Code No. ~o. 
P11r,c 2 
J Df.f-:1'1 F J CATJ O!l 
--· 
Patient Uur. 1.H•r 
Name~ c;-1 ..L,c, 
Laat 
n,~t.l 
First M. 1. 
Date f! l~'-1:/._ 
Study l'crJod: 
, 
PLAQUF. A~:r> CI~•GIVITIS SCORI~lG 
l'{J_ B,1:acl 1 nc 
(!j Wc<'k 3 
D Weck 6 
The tooth numbering system as 
diagramcd at the right is to be 
used in scoring. 
t 
I 
• • • 
,., ..... , u, r ER "4Tlr.,,•, 
Atc."r &.llT 
tr~t11JUboo D uut1tJO 
I 2 3 'I 5 6 7 8 5 10 11 11 I) l'f IS H 
L 0\.i/£ R 
' • 
' t 
,rLAQUE SCORE: Tooth 
No. 
Vertical Section 
of Tooth 
Total (sum of vertical 
Score sections 1,2,3) 
3 
1 ·::>. 
2 3 
3 ~ -----~- 3 
,._....., ________ ..,.._ --- - - -- -- - --------
9 
1 --"'3..._ _ 
2 ~ 
------ -
___.?_, 
3 ___ :l... ___ _ 
-~--~---.----,-.-------------------
1 3 
-------
12 2 ___ ~---
--..9,...._._ 12 
3 ___ 3 ___ _ 
-- - - ·-- - ..., _ - - -- - - -- - -- - ·---- - ·-1 ___ ?--____ _ 
19 2 3 
-------
_i ___ 19 
3 3 
-------_,_,, ___ ,_, ____________ ,_., ________ _ 
25 
'.l. l ______ _ 
2 __ ":). ___ _ {, 25 
----
3 __ ~----
--·-- - -~- - -.- ..... - - -- - -- - - - .__, - -.-. ,...._ 
28 
1 . .-:,_ 
-------
2 __ d-~--
3 __ ') __ 
_J_2s 
Crand Total (sum of totals for teeth 3,9,12,19,25, and 28): 
C0Htl£N_TS ---------------------------------
-
__ -...=-...~~~~~~L7"-4-Y __ _ 
O.:atc lnV<'S tlfta Lor S S gn ,, l urc 
• D.D.S. 
llhlto- Marion Hcdlcal Yellow- Hart~n as.llJtatlstica • Pink- Invcaticntor 
... 
. 
' I 
t 
• 
' ' 1 
,. 
J\P-100 (cn1.ym ! 111outhwash) /10)8 
Study No. 038_-001 
CAS~: l~f:PO!'T FUi :! 
• l ' L ·---·, r I 
- _L __ _l - -~ 
Principal lnvc!>tig:itor:, Henry Goldman, D.D.S. 
Pro, ucl Study P.1t J e nt 
Code No. No. 
lDENTIFJCATTO~~ ~ \ 
-- . ~'«-ll-('C> 
Name · . \ Cl\et 
I 
J.a~t 
To Break Code, Cut Across Upper 
Portion and Separate 
i' 038- 001 Patient bS -33 
.; 
n 
':I' 
l 
a 
PD- )C2740~ Treatment ~'} J~. l - 3 
7 
. 8 
g 
10 
PLEASE ATTACH THIS PORTION OF LABEL 
TO CASE RCPORT FOR .1-
\ 
MARIQN LABORATORIES, INC. 
KANSAS CITY, MISSOURI 64137 
B :). 
M ~ 
L ::l. 
D ::l. 
B :>. 
H I 
L • 
D a. 
B -:2. 
M :l 
L 3 
D ';\ 
B '::> 
H ;i 
L t 
D ~ 7 
Sum of Total Scores for Teeth 7,8, 
9, 10, 2 3 1 24 1 25, and 26: (, 0 
NOTE: Ba Buccal · M • Hesial 
. 
PATIENT INSTRUCTIO~S 
Patient ins true tions given: !8] Yes 
M. I. 
Pace 3 
Pat icnt Numhc1· 
Date ~ /~/ 'f'_ 
Study Period: ijJ n.,sclin 
LJ Week J 
0 Weck 6 
\CH TEAR-OFF PORTIO~ 
tfEDICATIO.l LABEL HCP.E 
Tooth 
No. 
23 
24 
25 
26 
Score for Tooth 
Surface 
B :, 
H ~ 
L !l. 
D I 
B 1 
M 3 
L 3 
D I 
B ~ 
M :2-
L :2 
D :;:l. 
B ':l 
H I 
L J-
D 
' 
Total Score 
for Tooth 
9 
• ~ 
• 32 • 
• 
_____ Gingivitis Score 
L • Lingual D-= Distal 
COMMENTS----------------------------- - -
,. 
, n.o.s. 
White- H3rion Medical Yellow- .~?ion Biostatistics Pink- Investigntor 
Al1-JOO (,·11,:~·•11l· moutltw.1 1 ,lt) C0)8 
. St u,ly Uu. _0 J8-_0Q l __ 
l'rJncJp.,J Jnvt·!aJJ~••Lu1: Henry Goldman, D.D.~_. ____ _ 
I _______ L .._ .. 1 .... __ .1 
l'rot.luc.:l Study l'.il 1<· 11t 
, 
Cod<• No. No • 
l'ui~ '• 
----- ---------------------------------------· --
1nI-::rr1 f 1 ct,T ro:i PD t i t • n l l-! u mt, · r 
----- -- --
._ __ ---
Nnme _&t:;__(;..£_0 __ -1'1 ____ / ~-4~ 
Last ~•j rs t 
D~tc -JI lf_J.:!_r 
PA1'1 tNT l'l:OGl'FSS 
------ . ------
Th<'rapy Sc:h0cluJ c: ~ / •· dircctl·d D Err~tic 
H.l. 
Study Pc-r:iocJ: ~ ~!t•ck 3 
• Wt! ·k 6 
(if erratic, cxpl.1jn: numbc1 of dos<.!s missed, dates, re~son tnissc<l) 
---------------------------------------- - - ---· 
MF.DlCATJON I\CCOliNTARll.ITY 
Week 3: Packets Used~+ Packets Returned 0 -
Week 6: Packets Used + Packets Returned 
-
42 
---
Totals for Study: Pack~tn Used + Packets Returned • 
---- ----
84 
Explain any unaccounted medication: 
---------------------------
CONCO:•tJTA.'T DRUGS (list all drugs whether prescription or proprietary) 
Drug Dose Dates (from-Lo) Renson for u~e 
• 
SIDE EFF[CTS (list any side effect or adverse reaction, date s of occurrence, severity, 
and relationship to the test medication) 
---- - ------------------- --------------------
----~-~'--
\ 
OV £RALL CO~lMENTS 
__ 1~/_LrLZC-,&.,'Y. __ _ 
,- l>atc 
83 
tihitc- HarJon Mcdic~l Yellow- Marion Biostatistics Pink- Investi&~tor 
• 
CA!, t: 1<1:PCI! 'f ro,e, 
AP-100 (t!n:...ym1.· r.,nuthw:,"l,1 10)8 
Study r:o._J).J8::00.l 
Principal lnv,•uti&Jtor: Henry Goldman, D.D.S. 
c ·~1-.. ·-~J'~- J 
Product Study l'.1lh .nt 
Code No. No. 
Pagr. 2 
1 or.t:TI FI C.ATT o:i 
- ----- -
P~ti~nt t:ur-1,t~r 
Naa\C~B<-.., 1-~--· .;....r-==Q~__.f._.,1'--1_...c__~·'Ar.;;;__--------
La.-t ;.·.1rs1. H.1. 
Da tc 'J I /'I /_ii:_-
PLAQUf. A~l!> CINCIVITIS SCORI~:C 
Study l'cr f nd: 0 B,.as 11 nc 
~Werk 3 
[j Weck 6 
I 
I 
• 
• 
,.,,,,,,., u, r £ R _..T,,.,,.J 
AIG>tll" 1 &.tlT 
The tooth numbering system as 
diagramcd at the right is to be 
used in scoring. 
ti~tJt11JDo o: oD l:iLJt18L1 
f 2 3 'I S t. 7 8 : 9 10 t I 11 ll l'f I !i I 6 
t 
~GJRQQOQUjfgQGeCj~~ 
PLAQUE SCORE: 
I 
LOWCR 
• I 
• I 
Tooth 
No. 
Vertical Section 
of Tooth 
Total (sw:n of vertical 
Score sections 1,2,3) 
l 
1 _ ___,.;:).;;___ __ 
2 ___ ::>-__ 
;;,.. 3 ______ _ 
_t~_J 
-----------------------------
1 __ 3-=----
9 2 ___ , __ _ _'7_9 
3 _· __.,3.....___ 
-----. •-·---- _________ ..._ ______ ....,_, 
1_-"""3 __ 
12 2 ___ 0 ___ _ 12 
----3_~3 ___ _ 
______ ,...,. _________ -- - - - -- ----------
19 
1 __ ~;...__-
2 __ _.;;').::;.._ __ 
l __ ;J. __ 
19 
__,...,. __ ,___, ___ --- -- ----- ------ -- - -
1 .:).. 
-------2 ___ ) __ s-· 
_ ___ 25 
3 ___ ':l.-__ _ 
______ . . _______________________ 
1 ___ ~ ... __;_--
28 2 ____ :;,.. __ _ 28 
----:)... 3 ______ _ 
,I 
Crand Total (sum of totals for teeth 3,9,12,19,25. and 28): 
COMMENTS------------- - ---------------------
-- ~U -Z:!.Ilflikt rl't/t'au. D.D.S. 
l est lg.1le\1Sf ~.1turc 
84 . 
4 
White- Marion Medical Yellow- Marlon Bioutatlstica Pink- lnvcsticator 
; 
• 
' 
• 
\ 
CASE rt:rOH.T J,(>f·:t 
AP-100 (cnzy1:,c t11outhwar;h) 0038 
Study No. 018-001 
Principal-lnvc::tigator: Henry Goldman, O.D.S. 
IDENTIFJCATlON 
Name _B-'; 1:.c.:_ r' ,} 
Last 
-----. ,_,... - - -
A; .t..:t-
1-·i rs t 
- -
To Break Code, Cut Across Upper 
Portion and Separate 
M. I. 
- -
Study l'criod: 
. L_L_l _____ J · 
ProJucl Stu<ly 1•~1ticnl 
C:odl! t:o. No. 
Pate 3 
PotJcnt Numh~r 
Date J_ 1/f I l.:/:_--
D B:1scl inc 
[$week 3 
d Weck 6 
~ 038· 001 
S' 
Patient jJ S - .3 3 ATTACII TI::AR-OFF POR'!.' 10:~ 
OF HED1CATI01 LABEL Hf.RE n 
:r PD- ) C, 2 7 4 0 4 
:c 
CD 
Treatment',•/ K. 4 - 6 
i PLEASE ATTACH THIS PORTION OF LABEL TO CASE REPORT FOR:.1-
MARION LABORATORIES, INC. 
KANSAS CITY, MISSOURI 64137 
e Tooth Score for Tooth Total Score for Tooth 
. -
. 
M ~ 
L 
' 
D J- ' 
8 B ~ 
M 1 
L 1 
D d-
9 B I 
M 
,_ 
L :l-
D ~ 
10 B 0 
M :l-
L I 
D 2 
Sum of Total Scores for Teeth 7,8, 
9,10,23,24,25, and 26: 
G 
7 
7 
NOTE: B m Buccal M • Hesial 
PATIENT INSTRUCTIONS 
Patient instructions given: ~ Yes 
No. Surface 
23 B 
' 
M ~ 
L b 
D 
;i. 
24 B 0 
M :3 
L 
' 
D I 
25 B I 
H d-
L 
' D ;J_ 
26 B () 
M 
~ ··-
~L , 
D '3 
• 
-
32 • _____ Gingivitis Score 
• L • Lingual D-= Distal 
COMMENTS , 
'1/nL!L----
• Datu 85 
Jrtu,2, //1u.tJ-l,•, tu,:e.~ ... 
· lnvcst~ignatur~ 
_, n. D. 
White- Marion Medical Yellow- H:irion Biostatistics 
Pink- Investigator 
.. 
t : l \ , i • 
- -- ·- - · ·- - L ____ .I. -·- . _i 
l'ro,hu : l r;1udy J•,,ti• •111 
AP-JOO (c•u z:,·111"· ntC.1 tli1.•,p. 1t) f.'038 
St utly No. _()J8-_0Q l_ . 
YrlncJ1,,1J lnv( ·~.Li1;ato1: __!!.cnry C<?ldman_1 D.D.S _. ____ _ CodC' No. !Jc• • 
)• it R<: I, 
---------------------------------- -- ----
Pat i l'n l NumlH: r 
Name f3..; I.:::_: J _g. ____ ✓-}_-~' -==.(..::.t./4~-- -------- Dote 3'I .5 1•J1/ __ _ 
La st first 
PA1'1 r.:'T Pl!OGJ• FSS 
H.l. 
Study PC"rioc.J: D t-!c.·ck 3 
[2('w e<:k 6 
ThC'r apy Sd1<.'clu Jc: Gl] Ar. <Ii r c:c:-tt:d [J l.:rr at i c 
(if erratic, cxpl~jn: number of dos •s mi~scd, dates, rea son mi~sc<l) 
------ --------------------------- ·--------------
MEDICATION ,\CC:nt:.·r,\Bll.ITY 
---
Week 3: Packets Used 'I'- + Packets Returned 
Week 6: Packets Used S,o + Packets Returned 
Totals for Study: Packetr. Used 2')- + Packets Returned 
/12 
42 
"L - 84 
Explaln any unaccounted medication: 
-------------------------
C0NC0:•11TA.~T nRur.s (list all drugs whether prescription or proprietary) 
Drug Dose Dates (Cro m-to) Reason for u~ 
• 
SIDE EFFECTS (l ist any side effect or adverse reaction, dates of occurrence, severity , 
and rcl ~tio nship to the test medication) 
~~~ -- -~t==Ot,;:;....;~,J... -...:.._-=-, ___________________________________ __ _ 
I 
.. 
OVERALL CO~t'tE. TS ------------------------- --- - - -------
__ V~PL?Y . , ll.D.S. 
Date 
White- ~farton Mcdic~l Yellow- HaMn Dior. at istics Pink- Investigator 
Al'-100 (<·n1.ymc.• mnuthw.ish) D0)8 
Study "o. _ _o 38.-001 
CASl:: kL1•(1f''f }lJ i'.I i -·~~-' 1-'J-~ J 
Pr 1 nc I p,11 1 n VC' !HJ c.1 tor : __ H_e_n_r_y __  G_o_l_d_m_a_n ___ , D_._D_. s_. ___ _ 
Product Study l'.1ticnl 
Code No. ~o. 
P11gc 2 
JDf.Nl 'J F 1 CATT O:l Patient t:urnbcr 
-----._._ ---
---
Name 73~ t· \!XO 
La~t 
A I..ILY-
r1rst M.1. 
Date~ 
Study rrrfod: • 8;tSC11nc 
0 Wc~k J 
PLAQUE A~;!) CING1VlT1S SCORe:c ~ Week 6 
' 
' • 
• 
,., ... ,., u r r c R ,..,,,.,,., 
'"" Mr I a.ti r 
The tooth numbering system as 
diagramcd at the right is to be 
used in scoring. 
t1~t1t1tJAoo: D UUtjrJO 
I ). 3 'I 5 y 7 8 ! 9 lo I I 1i ll l'I IS U 
• 
~QRQ ouou ioacroo ~ ~tj 
PLAQUE SCORE: 
Crand 
COMMENTS 
' 
LOWER 
' I 
• 
' 
Tooth 
No. 
Vertical Section 
of Tooth 
Total 
Score 
(sum •Of vertical 
sections 1,2,3) 
1 .2.. 
-------
3 2 ___ 1 __ _ 3 
----
3 :>-
-------
1 ~ 
9 
-------
2 ___ ~--- _G _____ 9 
3 ___ ~---
--------------------------------
1 ~ 
12 2 6 12 
------- ----3 __ ,g __ _ 
--------;--3--------------
19 2 I S- 19 
3 ___ 1 __ _ 
--- - ,__ ._. ~ ,._ - - - --..... - - - - --- --- - --,__ - ,_, .... . 
2S 
1 __ 3 __ _ 
2 ____ , __ _ 7 2S 
-----3 ___ 3 __ 
.... - .... --~ ,_ ,_ - - - - - - - - - - - - ---.................. - - ~ 
1 -~ ) 28 2 I 28 
3 d-
Total (sum of totals for teeth ),9,12,19,2S, and 28): 33 
---~~Y-~;,,,,c.1/--~--
r , -
Whltc- lbrion Hcd1cnl Yelle .... •. 1..,~ :itistlca Pink- Investigator 
D.D.S. 
I 
t l 
I 
' ; 
• 
' • ! 
• 
l 
. 
. 
I 
I 
' 
a 
' 
. 
l 
I 
r 
' I 
I 
, 
• 
... 
CASt: r1:ro r~T FOf~:-1 
Ar-100 (cn1.ym<' 1;1!tuthWcl!;h) li0)8 
Study No. 038-001 
. Principal-lnvt•~tig.;tor: Henry Goldm n 1 D.D.S. 
lDE~TIFJCATION 
· N:imc (-1,.._ .. ,._.. ~re 
Last •·1rs t M. I. 
~' • • I • t l • 
L.-. L~ L~--I 
ProJucl Study t• .. at icnt 
CoJc No. ~o. 
Par.c 3 
Pat ic11 t l~umhc-r 
Date _'fl 48" / '7CL 
- - - - __, -- --- - - ..... 
, I 
I 
Study l1crJorl: D Bnsclinc 
___ ,_,_ ___ _ 
. 
CINGIVITIS SCORE 
Tooth 
No. 
7 
8 
9 
• 
10 
Score for Tooth 
Surface 
B I 
M !l. 
- 0 L 
D .:).. 
B l 
M ~ 
L I 
D )-
B /. 
M 4 
L () 
D I 
B . 0 
M ~ 
L 0 
D ~ 
0 Weck 3 
g} Weck 6 I 
I 
_, 
ATf ACH TEAR-OFF PORTIO~~ 
OF MEDICATI0:1 Lt\OEL llLRE 
Total Score 
for Tooth 
Tooth 
No. 
23 
24 
25 
26 
Score for Too th 
Surface 
--B_-',,I __ 
H __ :;>... __ _ 
L __ .:t_,  
D __ -:2--__ _ 
B 0 . 
-----
M __ 3 ____  
L __ _.f..__ 
D ___ 1_ 
B f 
--- --M __ ?-__ _ 
L __ O,;;;._ _  
D 1 
-----
B" I 
-----
H 2-
L • __ f __ _ 
D __ 2-__ _ 
• 
Total Sore 
for Tooth 
Sum of Total Scores for Teeth 7,8, 
9,10,23,24,25, and 26: 
_!_ 32 • _____ Cinglvitis Score 
• 
NOTE: B • Buccal M • Hesial L • Lingual D • Distal 
PATIENT INSTRUCTIO~S 
Patient instructions given: g} Yes 
COMMENTS----------------------------------
Date 
White- Marion Medical 
88 
Yc.l&w- Marion Biostatistics 
, n.n.s. 
fink- Investig~tor 
• 
; 3 . .,- 0 ' > I 
,J L A 0 u r: {' 
/\ I) () 0 (J I. A C F u () A~-100 V:, JJLAC!=i1!> . 
, \,)tit" ~,:: •i F /: ~)I: , .. I( 3 I '• ' \ i~. ,) .1 - ,.. 6 - h I AS!: ' . ·~ rd\ 3 ·~ 6 3 ' . r, hA.:iE ul< J .. " (J rth - n .J - • 
" 
. . 
A . . \. ~ l\l ... ., . ' " I l ~ ..... • ~(J . ,11 ;> I C • • • ,2 - J •. >:,~; -~.J ( >,3 ;1: · • J f)i') ~u.'100 ~ I.J1~ 
. 
- J.:;00 - I • 1 , ,.J 
• • I • 
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